<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1-3.dtd?><?SourceDTD.Version 1.3?><?ConverterInfo.XSLTName jats2jats3.xsl?><?ConverterInfo.Version 1?><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Microorganisms</journal-id><journal-id journal-id-type="iso-abbrev">Microorganisms</journal-id><journal-id journal-id-type="publisher-id">microorganisms</journal-id><journal-title-group><journal-title>Microorganisms</journal-title></journal-title-group><issn pub-type="epub">2076-2607</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">9611931</article-id><article-id pub-id-type="doi">10.3390/microorganisms10101959</article-id><article-id pub-id-type="publisher-id">microorganisms-10-01959</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Discovery, Biosynthesis and Biological Activity of a Succinylated Myxochelin from the Myxobacterial Strain MSr12020</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-2695-4828</contrib-id><name><surname>Okoth</surname><given-names>Dorothy A.</given-names></name><xref rid="af1-microorganisms-10-01959" ref-type="aff">1</xref><xref rid="af2-microorganisms-10-01959" ref-type="aff">2</xref><xref rid="af3-microorganisms-10-01959" ref-type="aff">3</xref><xref rid="af4-microorganisms-10-01959" ref-type="aff">4</xref><xref rid="af5-microorganisms-10-01959" ref-type="aff">5</xref><xref rid="fn1-microorganisms-10-01959" ref-type="author-notes">&#x02020;</xref></contrib><contrib contrib-type="author"><name><surname>Hug</surname><given-names>Joachim J.</given-names></name><xref rid="af1-microorganisms-10-01959" ref-type="aff">1</xref><xref rid="af2-microorganisms-10-01959" ref-type="aff">2</xref><xref rid="af3-microorganisms-10-01959" ref-type="aff">3</xref><xref rid="af4-microorganisms-10-01959" ref-type="aff">4</xref><xref rid="fn1-microorganisms-10-01959" ref-type="author-notes">&#x02020;</xref></contrib><contrib contrib-type="author"><name><surname>Garcia</surname><given-names>Ronald</given-names></name><xref rid="af1-microorganisms-10-01959" ref-type="aff">1</xref><xref rid="af2-microorganisms-10-01959" ref-type="aff">2</xref><xref rid="af3-microorganisms-10-01959" ref-type="aff">3</xref><xref rid="af4-microorganisms-10-01959" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-1042-5665</contrib-id><name><surname>M&#x000fc;ller</surname><given-names>Rolf</given-names></name><xref rid="af1-microorganisms-10-01959" ref-type="aff">1</xref><xref rid="af2-microorganisms-10-01959" ref-type="aff">2</xref><xref rid="af3-microorganisms-10-01959" ref-type="aff">3</xref><xref rid="af4-microorganisms-10-01959" ref-type="aff">4</xref><xref rid="c1-microorganisms-10-01959" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Whitworth</surname><given-names>David</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-microorganisms-10-01959"><label>1</label>Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research (HZI), Department of Microbial Natural Products, Campus E8 1, Saarland University, 66123 Saarbr&#x000fc;cken, Germany</aff><aff id="af2-microorganisms-10-01959"><label>2</label>Department of Pharmacy, Saarland University, 66123 Saarbr&#x000fc;cken, Germany</aff><aff id="af3-microorganisms-10-01959"><label>3</label>German Center for Infection Research (DZIF), Partner Site Hannover-Braunschweig, 38124 Braunschweig, Germany</aff><aff id="af4-microorganisms-10-01959"><label>4</label>Helmholtz International Labs, Department of Microbial Natural Products, Campus E8 1, Saarland University, 66123 Saarbr&#x000fc;cken, Germany</aff><aff id="af5-microorganisms-10-01959"><label>5</label>Department of Chemistry, School of Physical and Biological Sciences, Main campus, Maseno University, Maseno P.O. Box 333-40105, Kenya</aff><author-notes><corresp id="c1-microorganisms-10-01959"><label>*</label>Correspondence: <email>rolf.mueller@helmholtz-hips.de</email></corresp><fn id="fn1-microorganisms-10-01959"><label>&#x02020;</label><p>These authors contributed equally to this work.</p></fn></author-notes><pub-date pub-type="epub"><day>30</day><month>9</month><year>2022</year></pub-date><pub-date pub-type="collection"><month>10</month><year>2022</year></pub-date><volume>10</volume><issue>10</issue><elocation-id>1959</elocation-id><history><date date-type="received"><day>08</day><month>9</month><year>2022</year></date><date date-type="accepted"><day>27</day><month>9</month><year>2022</year></date></history><permissions><copyright-statement>&#x000a9; 2022 by the authors.</copyright-statement><copyright-year>2022</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Myxobacteria feature unique biological characteristics, including their capability to glide on the surface, undergo different multicellular developmental stages and produce structurally unique natural products such as the catecholate-type siderophores myxochelins A and B. Herein, we report the isolation, structure elucidation and a proposed biosynthesis of the new congener myxochelin B-succinate from the terrestrial myxobacterial strain MSr12020, featuring a succinyl decoration at its primary amine group. Myxochelin-B-succinate exhibited antibacterial growth inhibition and moderate cytotoxic activity against selected human cancer cell lines. This unique chemical modification of myxochelin B might provide interesting insights for future microbiological studies to understand the biological function and biosynthesis of secondary metabolite succinylation.</p></abstract><kwd-group><kwd>myxochelin</kwd><kwd>myxobacteria</kwd><kwd>biosynthesis</kwd><kwd>natural products</kwd><kwd>secondary metabolites</kwd><kwd>succinylation</kwd><kwd>siderophore</kwd><kwd>succinyl-coenzyme A</kwd></kwd-group><funding-group><funding-statement>Research in Rolf M&#x000fc;ller&#x02019;s laboratory is funded by the Deutsche Forschungsgemeinschaft (DFG), the Bundesministerium f&#x000fc;r Bildung und Forschung (BMBF), and by the Deutsches Zentrum f&#x000fc;r Infektionsforschung Standort Hannover-Braunschweig. Dorothy A. Okoth acknowledges funding from a Humboldt Foundation postdoctoral fellowship.</funding-statement></funding-group></article-meta></front><body><sec sec-type="intro" id="sec1-microorganisms-10-01959"><title>1. Introduction</title><p>Iron is an essential element for most microorganisms [<xref rid="B1-microorganisms-10-01959" ref-type="bibr">1</xref>,<xref rid="B2-microorganisms-10-01959" ref-type="bibr">2</xref>]. Despite the abundance of iron in the earth&#x02019;s crust, it is not readily bioavailable in aerobic environments due to its low solubility. Therefore most bacteria produce low molecular weight iron scavenging secondary metabolites to obtain iron from their environment [<xref rid="B3-microorganisms-10-01959" ref-type="bibr">3</xref>,<xref rid="B4-microorganisms-10-01959" ref-type="bibr">4</xref>], which are defined as siderophores [<xref rid="B5-microorganisms-10-01959" ref-type="bibr">5</xref>]. These small, high-affinity iron-chelating secondary metabolites can be categorized into the four chemical classes catecholate, phenolate, hydroxamate and carboxylate types of siderophores on the basis of the structural moieties involved in iron chelation, whereby hybrids thereof are also commonly described [<xref rid="B4-microorganisms-10-01959" ref-type="bibr">4</xref>,<xref rid="B6-microorganisms-10-01959" ref-type="bibr">6</xref>]. Siderophores are typically synthetized by non-ribosomal peptide synthetases (NRPSs) modular multienzymes [<xref rid="B7-microorganisms-10-01959" ref-type="bibr">7</xref>], whereas a smaller fraction of siderophores is produced by pathways that are independent of NRPSs and polyketide synthases (PKSs) such as desferrioxamine [<xref rid="B8-microorganisms-10-01959" ref-type="bibr">8</xref>,<xref rid="B9-microorganisms-10-01959" ref-type="bibr">9</xref>] or quinolobactin [<xref rid="B10-microorganisms-10-01959" ref-type="bibr">10</xref>].</p><p>Myxobacteria not only display exceptional biological characteristics such as a complex chemical communication systems, multicellular development stages and the capability to move in coordinated manner to prey on other microorganisms [<xref rid="B11-microorganisms-10-01959" ref-type="bibr">11</xref>] but are also producers of chemically exceptional and bioactive secondary metabolites [<xref rid="B12-microorganisms-10-01959" ref-type="bibr">12</xref>]. Two different chemical types of siderophores are known to date from myxobacteria: the hydroxamate-type nannochelins [<xref rid="B13-microorganisms-10-01959" ref-type="bibr">13</xref>] and the catecholate-type hyalachelins [<xref rid="B14-microorganisms-10-01959" ref-type="bibr">14</xref>] and myxochelins [<xref rid="B15-microorganisms-10-01959" ref-type="bibr">15</xref>,<xref rid="B16-microorganisms-10-01959" ref-type="bibr">16</xref>], of which the latter have been investigated thoroughly in the last three decades [<xref rid="B17-microorganisms-10-01959" ref-type="bibr">17</xref>,<xref rid="B18-microorganisms-10-01959" ref-type="bibr">18</xref>,<xref rid="B19-microorganisms-10-01959" ref-type="bibr">19</xref>].</p><p>The myxochelins are produced by numerous myxobacterial strains including <italic toggle="yes">Stigmatella aurantica</italic> sg a15 [<xref rid="B20-microorganisms-10-01959" ref-type="bibr">20</xref>], <italic toggle="yes">Sorangium cellulosum</italic> So ce56 [<xref rid="B21-microorganisms-10-01959" ref-type="bibr">21</xref>], <italic toggle="yes">Myxococcus xanthus</italic> DK 1622 [<xref rid="B22-microorganisms-10-01959" ref-type="bibr">22</xref>,<xref rid="B23-microorganisms-10-01959" ref-type="bibr">23</xref>] and <italic toggle="yes">Angiococcus disciformis</italic> An d30 [<xref rid="B15-microorganisms-10-01959" ref-type="bibr">15</xref>] to maintain their iron homeostasis since it is indispensable for microbial viability [<xref rid="B20-microorganisms-10-01959" ref-type="bibr">20</xref>]. These myxobacterial siderophores have been occasionally described or associated with other bacteria such as the actinomycetes <italic toggle="yes">Nonomuraea</italic> sp. TP-A0861 [<xref rid="B24-microorganisms-10-01959" ref-type="bibr">24</xref>] and <italic toggle="yes">Steptomyces albicus</italic> m-9-20 [<xref rid="B25-microorganisms-10-01959" ref-type="bibr">25</xref>] or the <italic toggle="yes">Chloroflexi</italic> bacterium <italic toggle="yes">Herpetosiphon aurantiacus</italic> [<xref rid="B26-microorganisms-10-01959" ref-type="bibr">26</xref>]. Recently a number of new myxochelin derivatives have been isolated from different myxobacterial strains in which the common 2,3-dihydroxybenzoic acid has been replaced by a nicotinic acid moiety [<xref rid="B17-microorganisms-10-01959" ref-type="bibr">17</xref>] or a 4,5-dihydroimidazole moiety [<xref rid="B27-microorganisms-10-01959" ref-type="bibr">27</xref>]. Due to the relative simple structure of the myxochelins, chemical synthetic efforts led not only to the diversification of the aromatic scaffold [<xref rid="B17-microorganisms-10-01959" ref-type="bibr">17</xref>,<xref rid="B28-microorganisms-10-01959" ref-type="bibr">28</xref>] but also to the generation of <italic toggle="yes">hexa</italic><italic toggle="yes">dentate</italic> siderophores termed myxochelin C&#x02013;F [<xref rid="B16-microorganisms-10-01959" ref-type="bibr">16</xref>]. In addition, more myxochelin derivatives have been generated biotechnologically by precursor-directed biosynthesis [<xref rid="B29-microorganisms-10-01959" ref-type="bibr">29</xref>]. However, to the best of our knowledge, except for myxochelin C, none of the described naturally produced myxochelins feature a modification of the primary alcohol or amino group.</p><p>We hereby report the isolation, full structure elucidation and propose a biosynthetic pathway leading to the uniquely modified myxochelin congener myxochelin-B-succinate (<bold>1</bold>) from the myxobacterial strain MSr12020 along the re-isolated congeners myxochelins B (<bold>2</bold>) and A (<bold>3</bold>) (<xref rid="microorganisms-10-01959-f001" ref-type="fig">Figure 1</xref>). The genetic origin of <bold>1</bold>&#x02013;<bold>3</bold> was identified by in silico analysis and the biosynthetic conversion from <bold>2</bold> to <bold>1</bold> was further probed by in vitro reactions with the highly reactive intracellular metabolite succinyl-coenzyme A (succinyl-CoA) in order to reveal the non-enzymatic succinylation leading to the formation of <bold>1</bold>.</p></sec><sec id="sec2-microorganisms-10-01959"><title>2. Materials and Methods</title><sec id="sec2dot1-microorganisms-10-01959"><title>2.1. Maintenance of Myxobacterial Cultures</title><p>The myxobacterial strain MSr12020 was cultivated in VY/2 medium [%, (<italic toggle="yes">w</italic>/<italic toggle="yes">v</italic>) 0.2 soytone (BD), 0.3 casitone (BD), 0.2 glucose (Sigma-Aldrich), 0.8 soluble starch (Roth), 0.15 Yeast extract (BD), 0.1 CaCl<sub>2</sub> x 2H<sub>2</sub>O, 0.1 MgSO<sub>4</sub> x 7H<sub>2</sub>O, 50 mM HEPES, 8 mg/L Fe-EDTA, pH adjusted to 7.2 with 10N KOH before autoclaving] containing 5% (<italic toggle="yes">v</italic>/<italic toggle="yes">v</italic>) cell inoculum and 2% (<italic toggle="yes">v</italic>/<italic toggle="yes">v</italic>) amberlite resin XAD-16 (Sigma) for 14 days at 160 rpm, 30 &#x000b0;C. At the end of fermentation, resin and cells were harvested together by centrifugation at 8000 rpm, 30 min, 4 &#x000b0;C.</p></sec><sec id="sec2dot2-microorganisms-10-01959"><title>2.2. Standardized HPLC&#x02013;MS Conditions for Analysis of Secondary Metabolism of Crude Extracts</title><p>The broth extracts were analyzed by high-performance liquid chromatography&#x02013;high-resolution electrospray ionization-diode array-detector&#x02013;mass spectrometry (HPLC-HRESI-DAD-MS) on a maXis 4G mass spectrometer (Bruker Daltonics, Billerica, MA, USA) coupled with a Dionex UltiMate 3000 Rapid Separation (RS)LC system (Thermo Fisher Scientific, Waltham, MA, USA) using a BEH C18 column (100 &#x000d7; 2.1 mm, 1.7 &#x003bc;m) (Waters, Eschborn, Germany) with a gradient of 5&#x02013;95% acetonitrile (ACN) + 0.1% formic acid (FA) in H<sub>2</sub>O + 0.1% FA at 0.6 mL/min and 45 &#x000b0;C over 18 min with ultraviolet (UV) detection by a diode array detector (DAD) at 200&#x02013;600 nm. Mass spectra were acquired from 150 to 2000 <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> at 2 Hz. Detection was performed in the positive MS mode. The plugin for Chromeleon Xpress (Thermo Fisher Scientific, Waltham, MA, USA, version 6.8) was used for operation of the Dionex UltiMate 3000 RSLC system. HyStar (Bruker Daltonics, Billerica, MA, USA, version 3.2) was used to operate on the maXis 4G mass spectrometer system. HPLC-MS mass spectra were analyzed with DataAnalysis (Bruker Daltonics, Billerica, MA, USA, version 4.2).</p><p>In order to conduct statistical metabolome analysis to identify alternative producers of <bold>1</bold>&#x02013;<bold>3</bold>, both the myxobacterial strain and medium blanks were cultivated and extracted in triplicates as described elsewhere [<xref rid="B17-microorganisms-10-01959" ref-type="bibr">17</xref>]. Each crude extract was measured as technical duplicates yielding a total number of six replicates for the bacterial and medium blank extracts. T-ReX-3D molecular feature finder of MetaboScape 6.0.2 (Bruker Daltonics, Billerica, MA, USA) was used to obtain molecular features. Detection parameters were set to intensity threshold 5 &#x000d7; 10<sup>3</sup> and minimum peak length of five spectra. Identification of bacterial features was performed with the built-in t-test routine and filtered to appearance in all six bacterial extracts and in none of medium blank extracts. The in-house standard extract database embedded in the software bundle Mxbase Explorer 3.2.27 was used for the search of alternative producers of <bold>1</bold>&#x02013;<bold>3</bold>. The molecular formula and experimentally determined retention times of ions typically observed from the myxochelins were used as data input.</p></sec><sec id="sec2dot3-microorganisms-10-01959"><title>2.3. Isolation of <italic toggle="yes"><bold>1</bold>&#x02013;<bold>3</bold></italic> Via Liquid&#x02013;Liquid Extraction, Flash Chromatography and Semi-Preparative HPLC</title><p>The myxobacterial strain MSr12020 was cultivated in 26 L bufVY/2 medium containing 5% (<italic toggle="yes">v</italic>/<italic toggle="yes">v</italic>) cell inoculum and 2% (<italic toggle="yes">v</italic>/<italic toggle="yes">v</italic>) amberlite resin XAD-16 for 14 days at 160 rpm, 30 &#x000b0;C. At the end of fermentation, wet cell mass and adsorber resin XAD-16 were harvested together by centrifugation at 8000 rpm, 30 min and 4 &#x000b0;C. The crude extract was obtained from the fermentation broth via liquid acetone extraction; afterwards the acetone extract was dried under vacuum. The dried acetone extract (10.4 g) was then partitioned between methanol (MeOH) and <italic toggle="yes">n</italic>-hexane to remove fats. The MeOH layer was dried under vacuum to yield 6.6 g of extract. This extract was again sequentially partitioned in H<sub>2</sub>O and chloroform (CHCl<sub>3</sub>) followed by ethyl acetate (EA) partitioning. The non-aqueous extracts were dried in vacuo while the water portion was freeze-dried by lyophilization to yield a CHCl<sub>3</sub> (2.86 g), EA (1.94 g) and H<sub>2</sub>O (1.8 g) extract. Each liquid&#x02013;liquid extraction fraction was monitored for the presence of <bold>1</bold>&#x02013;<bold>3</bold> via HPLC-MS as described above. Myxochelins <bold>1</bold>&#x02013;<bold>3</bold> were detected in the EA and H<sub>2</sub>O residue.</p><p>The EA and H<sub>2</sub>O extracts revealed similar HPLC-MS profiles and were combined after evaporation of solvents. The extract was initially separated on a flash chromatography on an Isolera&#x02122;One (Biotage, Uppsala, Sweden) with a SNAP 100 g column packed with C18-Reverse phase silica gel (70 &#x000c5;, 200&#x02013;400 mesh, 40&#x02013;75 &#x003bc;m) using H<sub>2</sub>O (0.1% FA) as solvent <bold>A</bold>, ACN (0.1% FA) as solvent <bold>B</bold>, and acetone (0.1% FA) as solvent <bold>C</bold>. The flow rate was 50 mL/min, UV/VIS absorption was set at 250 and 312 nm. Collected fractions (45 mL) were monitored on a Dionex UltiMate 3000 RSLC system (Thermo Fisher Scientific, Waltham, MA, USA) coupled to an amaZon ion trap MS (Bruker Daltonics, Billerica, MA, USA). The elution gradient consisted of an initial isocratic mixture of 95:5% (H<sub>2</sub>O:ACN) for five column volumes (CVs), then ramped to 70:30% (H<sub>2</sub>O:ACN) for 10 CV. The gradient was held at 70:30 (H<sub>2</sub>O:ACN) for five CVs before being raised again to 5:95% (H<sub>2</sub>O:ACN) for 25 CVs. This was followed by an isocratic solvent system 5:95% (H<sub>2</sub>O:ACN) for five CVs. Similar fractions, based on mass profiles were pooled together. Fractions 38&#x02013;42 and 55&#x02013;63 contained the molecular masses of interest and were dried under vacuum to yield 76 mg and 43.2 mg respectively.</p><p>The flash chromatography fractions 38&#x02013;42 and 55&#x02013;63 were purified on UltiMate 3000 semi-preparative system coupled to a Thermo Scientific Dionex UltiMate 3000 Series automated fraction collector (Bruker Daltonics, Billerica, MA, USA) using a XSelect CSH C<sub>18</sub> Prep column, 5 &#x003bc;m, 10 &#x000d7; 250 mm (Waters TM) and eluted with H<sub>2</sub>O (0.1% FA) and ACN (0.1% FA). The fractions were monitored by mass spectrometry and by using the UV/VIS detector set at 220, 250, 312, and 400 nm. The gradient program was adjusted to an initial isocratic gradient 95:5% (H<sub>2</sub>O:ACN) for 3 min followed by gradient ramp to 16:84 (H<sub>2</sub>O:ACN) in 5 min. The gradient was then raised to 17:83% (H<sub>2</sub>O:ACN) for 23 min and then raised again to 5:95% (H<sub>2</sub>O:ACN) in 5 min and held for 2 min before lowering the gradient back to 95:5% (H<sub>2</sub>O:ACN) in 1 min. The column was re-equilibrated for 5 min using 95:5% (H<sub>2</sub>O:ACN). Compound <bold>2</bold> and <bold>3</bold> were detected using mass spectrometry on the Agilent 1100 series (Agilent Technologies, Santa Clara, CA, USA) coupled to the HCT 3D ion trap (Bruker Daltonics, Billerica, MA, USA) or with a UV detector on the Dionex UltiMate 3000 RSLC system by UV absorption at 220, 250, 312, and 400 nm. Fraction 38&#x02013;42 yielded compound <bold>2</bold> at a retention time of 10 min while fraction 55&#x02013;63 led to isolation of compounds <bold>1</bold> and <bold>3</bold> at retention times 16 min and 18 min respectively. The HPLC fractions were dried under N<sub>2</sub> yielding compound <bold>1</bold> (7.4 mg), <bold>2</bold> (12.2 mg) and <bold>3</bold> (4.9 mg).</p><p>The identity and chemical purity of <bold>1</bold>&#x02013;<bold>3</bold> was confirmed and monitored before NMR analysis via HPLC-HRESI-DAD-MS as described above (2.2), with the exception that the gradient of 5&#x02013;95% (H<sub>2</sub>O&#x02013;ACN) + 0.1% FA) at 0.6 mL/min and 45 &#x000b0;C was conducted over 9 min (termed &#x0201c;Short standardized HPLC&#x02013;MS condition&#x0201d;).</p><p>Myxochelin-B-succinate (<bold>1</bold>): pale brown paste; <inline-formula><mml:math id="mm400" display="block" overflow="scroll"><mml:mrow><mml:msubsup><mml:mrow><mml:mo stretchy="false">[</mml:mo><mml:mi mathvariant="sans-serif">&#x003b1;</mml:mi><mml:mo stretchy="false">]</mml:mo></mml:mrow><mml:mi mathvariant="normal">D</mml:mi><mml:mn>25</mml:mn></mml:msubsup></mml:mrow></mml:math></inline-formula> &#x02212;12.2 (<italic toggle="yes">c</italic> 0.5, MeOH), UV (MeOH) &#x003bb;<sub>max</sub> nm (log &#x003b5;): 210 (4.82), 248 (4.4), 312 (2.89) nm; <sup>1</sup>H and <sup>13</sup>C NMR, <xref rid="app1-microorganisms-10-01959" ref-type="app">Table S1</xref>; HR&#x02013;ESITOFMS (<italic toggle="yes">m</italic>/<italic toggle="yes">z</italic>): [M+H]<sup>+</sup> calcd for C<sub>24</sub>H<sub>30</sub>N<sub>3</sub>O<sub>9</sub>, 504.1977; found 504.1976; &#x00394; 0.2 ppm, retention time 5.52 min (according to standardized HPLC&#x02013;MS conditions in 2.2).</p><p>Mxochelin B (<bold>2</bold>): pale brown powder; <inline-formula><mml:math id="mm401" display="block" overflow="scroll"><mml:mrow><mml:msubsup><mml:mrow><mml:mo stretchy="false">[</mml:mo><mml:mi mathvariant="sans-serif">&#x003b1;</mml:mi><mml:mo stretchy="false">]</mml:mo></mml:mrow><mml:mi mathvariant="normal">D</mml:mi><mml:mn>25</mml:mn></mml:msubsup></mml:mrow></mml:math></inline-formula> &#x02212;9.2 (<italic toggle="yes">c</italic> 0.5, MeOH), UV (MeOH) &#x003bb;<sub>max</sub> nm (log &#x003b5;): 208(4.21) 246 (4.4), 312 (2.89) nm; <sup>1</sup>H and <sup>13</sup>C NMR, <xref rid="app1-microorganisms-10-01959" ref-type="app">Table S2</xref>; HR&#x02013;ESITOFMS (<italic toggle="yes">m</italic>/<italic toggle="yes">z</italic>): [M+H]<sup>+</sup> calcd for C<sub>20</sub>H<sub>26</sub>N<sub>3</sub>O<sub>6</sub>, 404.1817; found, 404.1819; &#x00394; 0.5 ppm, retention time 4.00 min (according to standardized HPLC&#x02013;MS conditions in 2.2).</p><p>Myxochelin A (<bold>3</bold>): pale brown powder; <inline-formula><mml:math id="mm402" display="block" overflow="scroll"><mml:mrow><mml:msubsup><mml:mrow><mml:mo stretchy="false">[</mml:mo><mml:mi mathvariant="sans-serif">&#x003b1;</mml:mi><mml:mo stretchy="false">]</mml:mo></mml:mrow><mml:mi mathvariant="normal">D</mml:mi><mml:mn>25</mml:mn></mml:msubsup></mml:mrow></mml:math></inline-formula> &#x02212;8.6 (<italic toggle="yes">c</italic> 0.5, MeOH), UV (MeOH) &#x003bb;<sub>max</sub> nm (log &#x003b5;): 210 (4.35) (4.21) 248 (4.4), 312 (2.89) nm; <sup>1</sup>H and <sup>13</sup>C NMR, <xref rid="app1-microorganisms-10-01959" ref-type="app">Table S3</xref>; HR&#x02013;ESITOFMS (<italic toggle="yes">m</italic>/<italic toggle="yes">z</italic>): [M+H]<sup>+</sup> calcd for C<sub>20</sub>H<sub>25</sub>N<sub>2</sub>O<sub>7</sub>, 405.1657; found 405.1658; &#x00394; 0.2 ppm, retention time 5.49 min (according to standardized HPLC&#x02013;MS conditions in 2.2).</p></sec><sec id="sec2dot4-microorganisms-10-01959"><title>2.4. NMR Based Structure Elucidation and Chiroptical Measurement</title><p>The chemical structures of <bold>1</bold>&#x02013;<bold>3</bold> were determined via multidimensional NMR analysis. <sup>1</sup>H-NMR, <sup>13</sup>C-NMR and 2D spectra were recorded at 500 MHz (1H)/175 MHz (<sup>13</sup>C), conducting an Ascend 500 spectrometer using a cryogenically cooled triple resonance probe (Bruker Biospin, Rheinstetten, Germany). Samples were dissolved in CD<sub>3</sub>OD. Chemical shifts are reported in ppm relative to tetramethylsilane; the solvent was used as the internal standard (<xref rid="app1-microorganisms-10-01959" ref-type="app">Supplementary Materials</xref>, <xref rid="app1-microorganisms-10-01959" ref-type="app">Figures S16&#x02013;S61</xref>).</p><p>Chiroptical rotation of <bold>1</bold>&#x02013;<bold>3</bold> was measured in MeOH using the polarimeter model 341 (PerkinElmer Inc., Waltham, MA, USA) in a 50 mm &#x000d7; 2 mm cell at 25 &#x000b0;C (<inline-formula><mml:math id="mm403" display="block" overflow="scroll"><mml:mrow><mml:msubsup><mml:mrow><mml:mo stretchy="false">[</mml:mo><mml:mi mathvariant="sans-serif">&#x003b1;</mml:mi><mml:mo stretchy="false">]</mml:mo></mml:mrow><mml:mi mathvariant="normal">D</mml:mi><mml:mn>20</mml:mn></mml:msubsup></mml:mrow></mml:math></inline-formula>). The sample solution concentration was 0.5 mg/mL. Circular dichroism measurements were performed for <bold>1</bold> at 0.5 mg/mL in MeOH (190&#x02013;400 nm) with the J-1500 CD spectrophotometer (JASCO, Easton, MD, USA).</p></sec><sec id="sec2dot5-microorganisms-10-01959"><title>2.5. Bioactivity Profiling</title><p>Antimicrobial activity was determined using agar diffusion assay [<xref rid="B30-microorganisms-10-01959" ref-type="bibr">30</xref>] paralleling previous bioactivity investigations of different myxochelins [<xref rid="B15-microorganisms-10-01959" ref-type="bibr">15</xref>,<xref rid="B31-microorganisms-10-01959" ref-type="bibr">31</xref>]. Single colonies of <italic toggle="yes">Staphylococcus aureus</italic>, <italic toggle="yes">Acinetobacter baumannii</italic> and <italic toggle="yes">Candida albicans</italic> were picked and inoculated into 8 mL TSB liquid medium, respectively. The overnight culture at 37 &#x000b0;C were diluted to 1 &#x000d7; 10<sup>7</sup> cells/mL with TSB liquid medium. The respective compound was dissolved in MeOH (5 mg/mL), and 5 &#x003bc;L of the solution was applied on a paper disk (Cytiva Whatman<sup>&#x000ae;</sup> Antibiotic Assay Discs, 6 mm diameter). The disks were then placed onto an agar plate containing a soft agar overlay of the test microorganisms. Kanamycin (antimicrobial standard agent against Gram-negative bacterial microorganisms), fusidic acid (antimicrobial standard agent against Gram-positive bacterial microorganisms) and cycloheximide (antimicrobial standard agent against Gram-positive fungi) at a concentration of 5 mg/mL were used as positive controls, and the solvent MeOH or dimethyl sulfoxide (DMSO) as the negative control. After incubation at 37 &#x000b0;C for 18 h, growth inhibition zones (in mm) were recorded as antimicrobial activity.</p><p>Carcinoma cell line HCT-116, DSMZ No. ACC 581, KB-3-1 (cervix carcinoma cell line, DSMZ No. ACC 158) and U2OS (human bone osteosarcoma epithelial cells) were cultured in RPMI 1640 medium supplemented with 10% fetal bovine serum 100 U/mL penicillin and 100 &#x003bc;g/mL streptomycin, respectively. Media and supplements were purchased from Sigma-Aldrich (St. Louis, MO, USA). The cells were incubated in 5% CO<sub>2</sub> at 37 &#x000b0;C until they reached approximately 50&#x02212;70% confluence, and then treated with various concentrations of compounds dissolved in water. DMSO was used as the negative control. An MTT [(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide), Sigma, St. Louis, MO, USA] assay was used to measure the proliferation of cells (6 x 10<sup>3</sup> cells) treated with different compounds in 96-well plates. After 24 h treatment with DMSO, different concentrations of tested compounds, as well as the positive control doxorubicin in DMSO, the cells were incubated with 10 &#x003bc;L of MTT<sup>32</sup> (5 mg/mL) for 4 h at 37 &#x000b0;C. The medium was discarded, and cells were washed with 100 &#x003bc;L PBS before adding 100 &#x003bc;L isopropanol/10 N HCl (250:1) in order to dissolve formazan granules. The absorbance at 570 nm was measured using a microplate reader (Tecan Infinite M200Pro). Cell viability was expressed as percentage relative to the respective DMSO control. The IC<sub>50</sub> values were determined by sigmoidal curve fitting using GraphPad PRISM 8 (GraphPad Software, San Diego, CA, USA). All bioactivity experiments were conducted as triplicates.</p></sec><sec id="sec2dot6-microorganisms-10-01959"><title>2.6. In Vitro Succinylation Reactions of <italic toggle="yes"><bold>2</bold></italic> and <italic toggle="yes"><bold>3</bold></italic></title><p>Non-enzymatic succinylation reactions of <bold>2</bold> and <bold>3</bold> were tested in a reaction mixture (100 &#x000b5;L volume) containing 1 &#x003bc;M <bold>2</bold> or <bold>3</bold> and 100 &#x003bc;M succinyl-CoA (Sigma-Aldrich (St. Louis, MO, USA); succinyl coenzyme A sodium salt, CAS: 108347-97-3) or succinate acid (Sigma-Aldrich (St. Louis, MO, USA); succinic acid disodium salt, CAS: 150-90-3) in DPBS buffer (Dulbecco&#x02019;s Phosphate Buffered Saline, (Sigma-Aldrich (St. Louis, MO, USA). The experimental setting of the performed in vitro reactions with regard to intracellular concentration of succinyl CoA in (myxo)bacteria, approximately resembles the value of ~ 230 &#x000b5;M found in <italic toggle="yes">E. coli</italic> [<xref rid="B32-microorganisms-10-01959" ref-type="bibr">32</xref>]. Therefore, the performed non-enzymatic succinylation reactions are applicable to the physiological bacterial environment regarding the chosen concentration of succinyl CoA and ratio to its substrate. Due to the instability of succinyl-CoA in aqueous solution [<xref rid="B33-microorganisms-10-01959" ref-type="bibr">33</xref>], the freshly prepared stock solution (10 mM) was immediately used for in vitro reactions. The pH and ionic strength of the DPBS buffer was adjusted by KOH and NaCl, respectively (pH 5.5/7.2/10.0). The reaction was carried out for 2.5 h at 30 &#x000b0;C in a 1.5 mL microcentrifuge tube. Negative control testing were performed by omitting succinyl-CoA or succinic acid. The mixture was subsequently transferred for centrifugation at 13,000&#x000d7; <italic toggle="yes">g</italic> for 15 min at 4 &#x000b0;C (VWR centrifuge ECN521-3601, Hitachi Koki Co., Ltd., Tokyo, Japan) and the SN was subjected to HPLC-MS analysis as described above.</p></sec><sec id="sec2dot7-microorganisms-10-01959"><title>2.7. Applied Software, DNA Sequence Analysis, and Bioinformatics Methods</title><p>Genomic DNA isolation and sequencing of myxobacterial strain MSr12020&#x02014;which belongs according to its 16S rRNA to a novel branch in a <italic toggle="yes">Polyangiaceae</italic> family and shows closest neighbor with <italic toggle="yes">Polyangium</italic> within the myxobacterial suborder Sorangiineae&#x02014;has been described previously by Okoth et al. [<xref rid="B34-microorganisms-10-01959" ref-type="bibr">34</xref>]. The MSr12020 genome was screened for secondary metabolite BGCs using the antiSMASH 6.0 [<xref rid="B35-microorganisms-10-01959" ref-type="bibr">35</xref>] online tool and the software Geneious Prime<sup>&#x000ae;</sup> (Biomatters Ltd., Auckland, New Zealand, 2020.0.5) [<xref rid="B36-microorganisms-10-01959" ref-type="bibr">36</xref>]. The nucleotide or amino acid sequence of interest was aligned with the basic local alignment search tool (BLAST) against our in-house genome database or the publicly available nucleotide database, in order to find homologous genes or proteins. The functional prediction of ORFs was performed by either using protein blast and/or blastx programs and Pfam [<xref rid="B37-microorganisms-10-01959" ref-type="bibr">37</xref>]. To obtain further information concerning the catalytic function of the identified biosynthetic proteins, the amino acid sequences were evaluated by the in silico protein homology analogy recognition engine 2 (Phyre2) [<xref rid="B38-microorganisms-10-01959" ref-type="bibr">38</xref>]. Raw data from the alignments for in silico evaluation of the myxochelin biosynthetic proteins were stored on the in-house server. Sequence alignments were performed with embedded Geneious alignment software with the following setups:</p><p>Pairwise alignments (alignment type: global alignment with free end gaps; cost matrix: Blosum62; gap open penalty: 12; gap extension penalty: 3). Multiple alignments (alignment type: global alignment with free end gaps; cost matrix: Blosum45; gap open penalty: 12; gap extension penalty: 3; refinement iterations: 2).</p><p>The nucleotide sequence of the myxochelin BGC originating from MSr12020 has been deposited in GenBank and is accessible under the accession number OP359050. The same nucleotide sequence will be implemented in the Minimum Information about a Biosynthetic Gene cluster (MIBiG) database. Further information concerning gene sequences can be found in the <xref rid="app1-microorganisms-10-01959" ref-type="app">Supplementary Information</xref>.</p></sec></sec><sec sec-type="results" id="sec3-microorganisms-10-01959"><title>3. Results</title><sec id="sec3dot1-microorganisms-10-01959"><title>3.1. Discovery, Isolation and Structural Elucidation of <italic toggle="yes"><bold>1</bold></italic></title><p>Cultivation of the myxobacterial strain MSr12020 was performed in VY/2 medium with supplementation of adsorber resin XAD-16. The secondary metabolome of MSr12020 revealed&#x02014;according to our in-house LC&#x02013;MS metabolome database termed Myxobase [<xref rid="B39-microorganisms-10-01959" ref-type="bibr">39</xref>]&#x02014;one previously uncharacterized myxochelin congener <bold>1</bold> and the known compounds <bold>2</bold> and <bold>3</bold> (<xref rid="microorganisms-10-01959-f002" ref-type="fig">Figure 2</xref>). A cultivation volume of 26 L containing bacterial cells and adsorber resin XAD-16 was extracted with acetone followed by liquid&#x02013;liquid extraction to yield a semi-crude EA and H<sub>2</sub>O extract. Both extracts were combined and separated via flash chromatography and the fractions containing compounds <bold>1</bold>&#x02013;<bold>3</bold> were further purified by semi-preparative HPLC. This resulted in compounds <bold>1</bold> (7.4 mg), <bold>2</bold> (12.2 mg) and <bold>3</bold> (4.9 mg).</p><p>Compound <bold>1</bold> was isolated as a brown solid with a molecular formula of C<sub>24</sub>H<sub>30</sub>N<sub>3</sub>O<sub>9</sub> as observed in the high-resolution mass spectrum (HRMS). A molecular ion of [M+H]<sup>+</sup> m/z of 504.1976 and <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 1007.3858 [2M+H]<sup>+</sup> was observed (calculated for 504.1977). The tandem MS (MS<sup>2</sup>) fragmentation was characterized by <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 486.19 (C<sub>24</sub>H<sub>28</sub>N<sub>3</sub>O<sub>8</sub><sup>+</sup>, [M-H<sub>2</sub>O+H]<sup>+</sup>), 444.21 (C<sub>23</sub>H<sub>30</sub>N<sub>3</sub>O<sub>6</sub><sup>+</sup>), 404.19 (C<sub>20</sub>H<sub>26</sub>N<sub>3</sub>O<sub>6</sub><sup>+</sup>, [M-succinyl+H]<sup>+</sup>), 387.15 (C<sub>20</sub>H<sub>23</sub>N<sub>2</sub>O<sub>6</sub><sup>+</sup>, [M-succinyl-NH<sub>2</sub>+H]<sup>+</sup>), 386.18 (C<sub>17</sub>H<sub>26</sub>N<sub>3</sub>O<sub>6</sub><sup>+</sup>, [M-dihdroxybenzoyl+H]<sup>+</sup>) due to loss of the dihydroxybenzoyl group), 350.17 (C<sub>17</sub>H<sub>24</sub>N<sub>3</sub>O<sub>5</sub><sup>+</sup>, [M-H<sub>2</sub>O-dihydroxybenzoyl+H]<sup>+</sup>), 268.16 (C<sub>13</sub>H<sub>22</sub>N<sub>3</sub>O<sub>3</sub><sup>+</sup>, [M-dihdroxybenzoyl-succinyl+H]<sup>+</sup>), 251.14 (C<sub>13</sub>H<sub>19</sub>N<sub>2</sub>O<sub>3</sub><sup>+</sup>, [M-dihdroxybenzoyl-succinyl-NH<sub>2</sub>+H]<sup>+</sup>), 234.11 (C<sub>13</sub>H<sub>16</sub>NO<sub>3</sub><sup>+</sup>), 214.15 (C<sub>10</sub>H<sub>20</sub>NO<sub>2</sub><sup>+</sup>, [M-H<sub>2</sub>O-2&#x000d7;dihydroxybenzoyl+H]<sup>+</sup>). The UV-VIS absorption of <bold>1</bold> at &#x003bb;<sub>max</sub> 212, 250 and 312 nm corresponds to &#x003c0;-&#x003c0;* transition of benzene ring of the dihydroxybenzoyl group [<xref rid="B40-microorganisms-10-01959" ref-type="bibr">40</xref>,<xref rid="B41-microorganisms-10-01959" ref-type="bibr">41</xref>].</p><p>The <sup>1</sup>H NMR spectrum showed six aromatic protons &#x003b4;<sub>H</sub> 6.92 (1H, <italic toggle="yes">dd</italic>, <italic toggle="yes">J =</italic> 1.45, 7.9 Hz, 4&#x02032;-H), 6.90 (1H, <italic toggle="yes">dd</italic>, <italic toggle="yes">J =</italic> 1.45, 8.0 Hz, 4&#x02033;-H), 6.70 (1H, <italic toggle="yes">dd</italic>, <italic toggle="yes">J =</italic> 7.9, 8.0 Hz, H-5&#x02032;), 6.68 (1H, <italic toggle="yes">dd</italic>, <italic toggle="yes">J =</italic> 7.86, 8.0 Hz, H-5&#x02033;) 7.18 (1H, <italic toggle="yes">dd</italic>, <italic toggle="yes">J =</italic> 1.45, 8.0 Hz, H-6&#x02032;) and &#x003b4;<sub>H</sub> 7.21 (1H, <italic toggle="yes">dd</italic>, <italic toggle="yes">J =</italic> 1.45, 8.0 Hz, H-6&#x02033;) whose coupling pattern and coupling constants suggested each ring had three neighboring protons in a 1,2,3 trisubstituted aromatic ring. The <sup>1</sup>H NMR spectrum also showed the presence of seven methylene signals &#x003b4;<sub>H</sub> 3.44 (1H, <italic toggle="yes">dd</italic>, <italic toggle="yes">J =</italic> 4.85, 13.8 Hz, H-1), 3.38 (2H, <italic toggle="yes">t</italic>, <italic toggle="yes">J =</italic> 7.0 Hz, H-6), 3.29 (1H, <italic toggle="yes">dd</italic>, <italic toggle="yes">J =</italic> 7.3, 13.8 Hz, H-1), 2.55 (2H, <italic toggle="yes">t</italic>, <italic toggle="yes">J =</italic> 6.85 Hz, H-3&#x02034;) 2.44 (2H, <italic toggle="yes">m</italic>, H-2&#x02034;), 1.67 (2H, <italic toggle="yes">m</italic>, H-3 and 1H, H-5) and &#x003b4;<sub>H</sub> 1.48 (2H, <italic toggle="yes">m</italic>, 4-H) and one methine proton &#x003b4;<sub>H</sub> 4.21(1H, <italic toggle="yes">m</italic>, H-2).</p><p>The <sup>13</sup>C NMR spectrum was characterized by one acid carbonyl &#x003b4;<sub>C</sub> 176.8 (C-4&#x02034;) and three amide carbonyls 175.5 (C-1&#x02034;), 171.8 (C-7&#x02033;), 171.7 (C-7&#x02032;), four oxygenated quartenary aromatic carbons &#x003b4;<sub>C</sub> 150.5 (C-2&#x02033;), 150.4 (C-2&#x02032;), 147.5 (C-3&#x02032;), 147.4 (C-3&#x02033;), six aromatic methines &#x003b4;<sub>C</sub> 119.8 (C-5&#x02032;), 119.7 (C-4&#x02032; and C-4&#x02033;), 119.7 (C-5&#x02033;), 118.9 (C-6&#x02033;), 118.7 (C-6&#x02032;), and two quaternary carbons &#x003b4;<sub>C</sub> 116.9 (C-1&#x02033;) and 116.9 (C-1&#x02032;). In addition, the <sup>13</sup>C NMR spectrum also indicated the presence of seven methylenes &#x003b4;<sub>C</sub> 44.1 (C-1), 40.4 (C-6), 32.6 (C-3), 31.9 (C-2&#x02034;), 30.7 (C-3&#x02034;), 30.3 (C-5), 24.6 (C-4) and one methine &#x003b4;<sub>C</sub> 51.2 (C-2) resonance. The presence of two dihydroxybenzamide groups was verified by <sup>1</sup>H-<sup>1</sup>H COSY H-4&#x02032;/H-5&#x02032; and H-5&#x02032;/H-6&#x02032; and <sup>1</sup>H-<sup>13</sup>C H-4&#x02032;/C-1&#x02032;,C-2&#x02032;, C-3&#x02032;, H-5&#x02032;/C-1&#x02032;, C-2&#x02032;, C-3&#x02032;, C-6&#x02032;, C-7&#x02032;, H-6&#x02032;/C-1&#x02032;, C-2&#x02032;, C-3&#x02032;, C-4&#x02032;, C-5&#x02032; and C-7&#x02032; HMBC correlations. The occurrence of an aliphatic alkyl chain -CH<sub>2</sub>-CH<sub>2</sub>-CH<sub>2</sub>-CH-CH<sub>2</sub>-partial structure was deduced from the H-1/H-2, H-2/H-3, H-3/H-4, H-5/-H-6 <sup>1</sup>H-<sup>1</sup>H correlations.</p><p>The observed <sup>1</sup>H-<sup>13</sup>C HMBC correlations between the H-6 and C-7&#x02033;, H-2 and H-C-7&#x02032; confirmed the chain being attached to the dihdroxybenzamide at C-7&#x02032; and C-7&#x02033;. The remaining two methylene groups and two carbonyls were assigned to the succinyl amide, inferred from the H-2&#x02034;/H-3&#x02034; COSY cross peaks and H-2&#x02034;/C-1&#x02034;, C-3&#x02034; and C-4&#x02034; and H-3&#x02034;/C-1&#x02034;and C-4&#x02034; HMBC interactions. It was noted that the succinyl moiety was connected to the aliphatic chain at H-1 based on observed H-1/C-1&#x02034; <sup>1</sup>H-<sup>13</sup>C HMBC interactions (<xref rid="microorganisms-10-01959-f003" ref-type="fig">Figure 3</xref>). Thus <bold>1</bold> was elucidated as myxochelin-B-succinate based on the similarities with the previously reported siderophore <bold>2</bold>. The negative optical rotation and the positive cotton effect observed for <bold>1</bold> (<xref rid="app1-microorganisms-10-01959" ref-type="app">Figure S12</xref>) were similar to those observed in naturally occurring and synthetic <bold>2</bold> and <bold>3</bold> -(2<italic toggle="yes">S</italic>)-isomer [<xref rid="B16-microorganisms-10-01959" ref-type="bibr">16</xref>,<xref rid="B17-microorganisms-10-01959" ref-type="bibr">17</xref>,<xref rid="B24-microorganisms-10-01959" ref-type="bibr">24</xref>,<xref rid="B28-microorganisms-10-01959" ref-type="bibr">28</xref>,<xref rid="B42-microorganisms-10-01959" ref-type="bibr">42</xref>].</p></sec><sec id="sec3dot2-microorganisms-10-01959"><title>3.2. Bioactivity of <italic toggle="yes"><bold>1</bold>&#x02013;<bold>3</bold></italic></title><p>Compound <bold>3</bold> was reported to be weakly active against a few Gram-positive bacteria, whereas Gram-negative bacteria, yeast and fungi are resistant against <bold>3</bold> [<xref rid="B15-microorganisms-10-01959" ref-type="bibr">15</xref>]. Compound <bold>2</bold> showed antibacterial activity against <italic toggle="yes">Salmonella typhumirium</italic> [<xref rid="B16-microorganisms-10-01959" ref-type="bibr">16</xref>]. The myxochelin congeners A and B are known to be active against different cancer and tumor cell lines [<xref rid="B24-microorganisms-10-01959" ref-type="bibr">24</xref>,<xref rid="B28-microorganisms-10-01959" ref-type="bibr">28</xref>,<xref rid="B40-microorganisms-10-01959" ref-type="bibr">40</xref>]. The antileukemic activity of the myxochelins can be explained through the inhibition of human 5-lipoxygenase. This well-known drug target [<xref rid="B43-microorganisms-10-01959" ref-type="bibr">43</xref>], which catalyzes the conversion of arachidonic acid to leukotrienes is involved in important inflammatory processes [<xref rid="B42-microorganisms-10-01959" ref-type="bibr">42</xref>,<xref rid="B44-microorganisms-10-01959" ref-type="bibr">44</xref>,<xref rid="B45-microorganisms-10-01959" ref-type="bibr">45</xref>]. Compound <bold>1</bold>&#x02013;<bold>3</bold> showed no antibacterial activity against the Gram-negative test strains (<xref rid="microorganisms-10-01959-t001" ref-type="table">Table 1</xref>), but <bold>1</bold> featured modest antibacterial activity against <italic toggle="yes">Micrococcus luteus</italic> (<xref rid="microorganisms-10-01959-f004" ref-type="fig">Figure 4</xref>) and moderate cytotoxic activity against the tested cancer cell lines being in line with <bold>2</bold> (<xref rid="microorganisms-10-01959-t002" ref-type="table">Table 2</xref>). In conclusion, the succinylation of <bold>2</bold> seems to affect its biological activity according to the observed performance in the conducted bioactivity assays.</p></sec><sec id="sec3dot3-microorganisms-10-01959"><title>3.3. Biosynthesis of <italic toggle="yes"><bold>1</bold>&#x02013;<bold>3</bold></italic></title><p>Genomic investigation of the myxobacterial strain MSr12020 led to the identification of a particular myxochelin-like biosynthetic gene cluster (BGC) that could be responsible for the biosynthesis of the new congener <bold>1</bold> and for the previously discovered compounds <bold>2</bold> and <bold>3</bold>. Although the architecture (localization of conserved myxochelin biosynthesis genes and surrounding accessory genes) of the identified genetic locus from MSr12020 deviates from previously investigated myxochelin BGCs (<xref rid="app1-microorganisms-10-01959" ref-type="app">Supplementary Materials</xref>, <xref rid="app1-microorganisms-10-01959" ref-type="app">Figure S13</xref>), the overall similarity regarding gene sequence identity, suggests a similar biosynthetic pathway leading to <bold>1</bold> and the known congeners <bold>2</bold> and <bold>3</bold> (<xref rid="microorganisms-10-01959-f005" ref-type="fig">Figure 5</xref>).</p><p>The myxochelin biosynthesis was elucidated by in vitro reconstitution of the complete biosynthetic pathway using the recombinantly produced core NRPS biosynthetic proteins MxcE&#x02013;G as well as MxcL in <italic toggle="yes">Escherichia coli</italic> [<xref rid="B18-microorganisms-10-01959" ref-type="bibr">18</xref>,<xref rid="B19-microorganisms-10-01959" ref-type="bibr">19</xref>,<xref rid="B21-microorganisms-10-01959" ref-type="bibr">21</xref>]. The biosynthesis of the myxochelins is initiated by ATP-dependent activation of 2,3-dihydroxybenzoic acid (2,3-DHBA) via the standalone adenylation domain MxcE. 2,3-DHBA is then transferred to the carrier protein of the bimodule MxcF, which contains an aryl-carrier protein (ArCP) domain and an isochorismate synthase (IC). Subsequently MxcF transfers two 2,3-DHBA units to MxcG for condensation with both, the &#x003b1;- and &#x003b5;-side-chain amino groups of the activated lysine. The PCP-bound thioester intermediate is reduced and thereby released from the enzyme complex to yield aldehyde <bold>4</bold> which can undergo NAD(P)-H dependent catalyzed reduction to generate the corresponding alcohol <bold>3</bold> or reductive transamination by MxcL to produce <bold>2</bold> (<xref rid="microorganisms-10-01959-f005" ref-type="fig">Figure 5</xref>).</p><p>Based on the elucidated chemical structure of <bold>1</bold>&#x02014;being a succinylated derivative of <bold>2</bold>&#x02014;the presence of a genetically conserved myxochelin BGC and the prolific production of <bold>2</bold> and <bold>3</bold>, it is reasonable to propose that <bold>2</bold> is the biosynthetic precursor of <bold>1</bold>. Therefore, it seems to be plausible that either a single enzyme is catalyzing the succinylation of <bold>2</bold> to yield <bold>1</bold> or a non-enzymatic reaction of <bold>2</bold> with the reactive intracellular metabolite succinyl-CoA generates <bold>1</bold>.</p><p>Since careful genomic in silico analysis of the identified myxochelin BGC in the myxobacterial strain MSr12020 did not result in a potential co-localized gene candidate, which was expected to encode a transferase responsible for the catalytic conversion of <bold>2</bold> to <bold>1</bold> (<xref rid="app1-microorganisms-10-01959" ref-type="app">Supplementary Materials</xref>, <xref rid="app1-microorganisms-10-01959" ref-type="app">Figure S13</xref>, <xref rid="app1-microorganisms-10-01959" ref-type="app">Table S5</xref>), we performed different in vitro reactions by incubating <bold>2</bold> or <bold>3</bold> with succinyl-CoA or succinate under physiological conditions in order to probe a possible non-enzymatic formation of <bold>1</bold>. As expected, incubation of <bold>2</bold> or <bold>3</bold> with succinate did not yield any observable reaction product, whereas incubation of <bold>2</bold> with succinyl-CoA in fact revealed minor production of <bold>1</bold> (<xref rid="microorganisms-10-01959-f006" ref-type="fig">Figure 6</xref>A). This non-enzymatic reaction was clearly pH dependent, since in vitro reactions performed at pH 5.5 did only show minute amounts of <bold>1</bold>, whereas the succinylation rate was highest at pH 10 (<xref rid="microorganisms-10-01959-f006" ref-type="fig">Figure 6</xref>B). Similar observations considering the pH dependency of non-enzymatic succinylation reactions have been reported previously [<xref rid="B46-microorganisms-10-01959" ref-type="bibr">46</xref>,<xref rid="B47-microorganisms-10-01959" ref-type="bibr">47</xref>]. Compound <bold>3</bold> was not succinylated under the tested conditions, which resembles the finding that we could not observe any myxochelin-A-succinyl derivative in the secondary metabolome of MSr12020. The higher nucleophilicity of the primary amine of <bold>2</bold> compared to the primary alcohol of <bold>3</bold> [<xref rid="B48-microorganisms-10-01959" ref-type="bibr">48</xref>] might provide a reasonable explanation for this observation. Therefore, a possible mechanism for the succinylation of <bold>2</bold> might comprise the nucleophilic attack of a primary amino group on the carbonyl carbon of the succinyl group in succinyl-CoA. Accordingly, an alkaline pH accelerates the formation of a highly reactive cyclic succinic anhydride intermediate, which can react with the primary amine of <bold>2</bold> [<xref rid="B49-microorganisms-10-01959" ref-type="bibr">49</xref>] (<xref rid="microorganisms-10-01959-f006" ref-type="fig">Figure 6</xref>C).</p><p>Due to the fact that myxochelin production is prevalent and conserved within the order of <italic toggle="yes">Myxococcales</italic>, we performed an extended survey investigating the occurrence of <bold>1</bold>&#x02013;<bold>3</bold> across myxobacterial taxa, using a previously established collection of high-resolution HPLC-MS datasets from approx. 2600 myxobacterial strains [<xref rid="B39-microorganisms-10-01959" ref-type="bibr">39</xref>]. The chosen parameters to evaluate those MS datasets considering the exact mass (exact mass deviation below 5 ppm), isotope pattern, and retention time matching (retention time deviation below 0.3 min) was adapted from a previous study investigating the presence of myxochelin congeners featuring nicotinic acid moieties [<xref rid="B17-microorganisms-10-01959" ref-type="bibr">17</xref>]. This metabolomic survey revealed that <bold>1</bold> is a commonly observed byproduct of myxochelin B biosynthesis (<xref rid="app1-microorganisms-10-01959" ref-type="app">Figure S14</xref>). The observed production titer of <bold>1</bold> displays a great bandwidth from being produced in trace amounts up to an equally produced congener such as <bold>3</bold> (<xref rid="app1-microorganisms-10-01959" ref-type="app">Figure S15</xref>). Similarly to the secondary metabolome of MSr12020, we could not observe any molecular ion, which might account for a myxochelin-A-succinyl derivative in these myxobacterial HPLC-MS datasets. It is worth mentioning that the production of iron-chelating myxochelins in myxobacteria is strongly depending on the availability of iron in the fermentation medium; consequently fermentation media supplemented with ferric ethylenediaminetetraacetic acid (EDTA) is abolishing myxochelin production [<xref rid="B17-microorganisms-10-01959" ref-type="bibr">17</xref>].</p><p>Taken together, these results do not entirely exclude that a tailoring enzyme is catalyzing the formation of <bold>1</bold> (in particular in those observed myxobacterial high producers), however such non-enzymatic succinylations of natural products seem not to be unprecedented as exemplified by the discovery of succinylated derivatives of the subclass IId bacteriocin BacSp222 [<xref rid="B47-microorganisms-10-01959" ref-type="bibr">47</xref>]. Overall, our results indicate that non-enzymatic conversion of <bold>2</bold> seems to be a reasonable route leading to the formation of <bold>1</bold>.</p></sec></sec><sec sec-type="discussion" id="sec4-microorganisms-10-01959"><title>4. Discussion and Conclusions</title><p>Succinylations as post-translational modification of proteins originating from bacteria, yeasts or animals were described in previous studies [<xref rid="B50-microorganisms-10-01959" ref-type="bibr">50</xref>,<xref rid="B51-microorganisms-10-01959" ref-type="bibr">51</xref>], whereas the modification in microbial secondary metabolite biosynthesis is a rather uncommon tailoring reaction. Examples of microbial natural products featuring succinyl substructures include the subtilin-like lantibiotic S-entianin [<xref rid="B52-microorganisms-10-01959" ref-type="bibr">52</xref>], the lipopeptides cerexins [<xref rid="B53-microorganisms-10-01959" ref-type="bibr">53</xref>] and succilins [<xref rid="B54-microorganisms-10-01959" ref-type="bibr">54</xref>], the tetrahydroisoquinolines perquinolines A&#x02013;C [<xref rid="B55-microorganisms-10-01959" ref-type="bibr">55</xref>], the nonpeptide hydroxamate siderophores desferrioxamine [<xref rid="B8-microorganisms-10-01959" ref-type="bibr">8</xref>], the fungal macrolides A26771B and berkeleylactone [<xref rid="B56-microorganisms-10-01959" ref-type="bibr">56</xref>], the 24-membered macrolide 7-<italic toggle="yes">O</italic>-succinyl macrolactin A [<xref rid="B57-microorganisms-10-01959" ref-type="bibr">57</xref>] and succinylated derivatives of the subclass IId bacteriocin BacSp222 (suc-K20-BacSp222 and suc-K11/suc-K20-BacSp222) [<xref rid="B47-microorganisms-10-01959" ref-type="bibr">47</xref>] (<xref rid="microorganisms-10-01959-f007" ref-type="fig">Figure 7</xref>). The perquinolines A&#x02013;C biosynthesis highlights a chemically interesting natural product assembly in which the biosynthesis is initiated by the condensation of succinyl-CoA and <sc>l</sc>-phenylalanine catalyzed by the amino-7-oxononanoate synthase-like enzyme PqrA [<xref rid="B55-microorganisms-10-01959" ref-type="bibr">55</xref>]. In the course of the biosynthesis of the fungal macrolide antibiotic A26771B, the acyltransferase BerkE catalyzes the succinylation of the biosynthetic intermediate berklactone C to the succinylated intermediate berkeleylactone E [<xref rid="B56-microorganisms-10-01959" ref-type="bibr">56</xref>]. The structural decoration of the 7-OH group of macrolactin A to its succinylated derivative <italic toggle="yes">O</italic>-succinyl macrolactin A is catalyzed by the a &#x003b2;-lactamase homolog BmmI, which could specifically attach C3&#x02013;C5 alkyl acid thioesters and also exhibit substrate promiscuity toward acyl acceptors with different scaffolds [<xref rid="B57-microorganisms-10-01959" ref-type="bibr">57</xref>].</p><p>Paralleling those aforementioned biosynthetic examples, the biosynthetic formation of the hydroxamate siderophores desferrioxamines involves the acyl-CoA-dependent acyl transferase DesC, which catalyzes the acylation of <italic toggle="yes">N</italic>-hydroxypentane-1,5-diamine (<italic toggle="yes">N</italic>-hydroxycadaverine) with succinyl- and acetyl-CoA to form <italic toggle="yes">N</italic>-hydroxy-<italic toggle="yes">N</italic>-acetyl-cadaverine (HAC) and <italic toggle="yes">N</italic>-hydroxy-<italic toggle="yes">N</italic>-succinyl-cadaverine (HSC) [<xref rid="B58-microorganisms-10-01959" ref-type="bibr">58</xref>]. While for those natural product classes the catalysis of succinylation was identified by acyl-transferase-like proteins, the underlying succinylation mechanism of other natural product classes such as the subtilin-like lantibiotic S-entianin [<xref rid="B52-microorganisms-10-01959" ref-type="bibr">52</xref>], the lipopeptides cerexins [<xref rid="B53-microorganisms-10-01959" ref-type="bibr">53</xref>] and succilins [<xref rid="B54-microorganisms-10-01959" ref-type="bibr">54</xref>] elusive at present.</p><p>In summary, this study describes the discovery, isolation, full structure elucidation and a possible biosynthetic pathway of <bold>1</bold> which shows in contrast to previous naturally and semi-synthetically produced myxochelins a unique succinylation decoration on the primary amino group. Although the biological and iron-chelation function of the succinyl group of <bold>1</bold> remains elusive, we observed that the succinylation of <bold>2</bold> leads to a significant reduction in antibacterial activity. In silico genome analysis of the myxobacterium MSr12020 revealed the genetic origin of <bold>1</bold>&#x02013;<bold>3</bold> and in vitro experiments display the possibility that <bold>1</bold> might be biosynthesized by non-enzymatic succinylation of <bold>2</bold> with the highly reactive intracellular metabolite succinyl-CoA. Further confirmation of this finding would hint towards interesting biological implications regarding the purpose of succinylation during the biosynthesis of natural products and as posttranslational modification. It seems that both enzymatic and non-enzymatic succinylations play a central role in living (micro)organisms [<xref rid="B59-microorganisms-10-01959" ref-type="bibr">59</xref>], and future studies might provide a better understanding concerning the imposing consequences of these chemical modifications. Thus, the discovery and proposed biosynthesis of <bold>1</bold> from the myxobacterium MSr12020 provides an intriguing puzzle piece of natural product succinylation.</p></sec></body><back><ack><title>Acknowledgments</title><p>The authors thank Stefanie Neuber, Irene Kochems, Viktoria George and Jennifer Herrmann for performing bioactivity assays, Nicolas Frank and Alexander Voltz for biosynthetic and analytic support, Judith Hoffmann for her assistance in structure elucidation and Nestor Zaburannyi for bioinformatics support.</p></ack><fn-group><fn><p><bold>Publisher&#x02019;s Note:</bold> MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><app-group><app id="app1-microorganisms-10-01959"><title>Supplementary Materials</title><p>The following supporting information can be downloaded at: <uri xlink:href="https://www.mdpi.com/article/10.3390/microorganisms10101959/s1">https://www.mdpi.com/article/10.3390/microorganisms10101959/s1</uri>, Figure S1: LC MS UV-VIS spectrum of myxochelin B-succinate (<bold>1</bold>); Figure S2: MS<sup>2</sup> fragmentation of myxochelin B-succinate (<bold>1</bold>), Figure S3: MS<sup>2</sup> fragmentation of myxochelin-B succinate (<bold>1</bold>); Figure S4: MS<sup>2</sup> spectrum of in vitro produced <bold>1</bold> (<bold>A</bold>) and authentic <bold>1</bold> (<bold>B</bold>); Figure S5: LC MS UV-VIS spectrum of myxochelin B (<bold>2</bold>); Figure S6: MS<sup>2</sup> fragmentation of myxochelin B (<bold>2</bold>); Figure S7: MS<sup>2</sup> spectrum of myxochelin B (<bold>2</bold>); Figure S8: LC MS UV-VIS spectrum of myxochelin A (<bold>3</bold>); Figure S9: MS<sup>2</sup> fragmentation of myxochelin A (<bold>3</bold>); Figure S10: MS<sup>2</sup> fragmentation of myxochelin A (<bold>3</bold>); Figure S11: MS<sup>2</sup> fragmentation scheme of <bold>1</bold> and proposed structure of identified key ions; Figure S12: CD spectrum of <bold>1</bold> at a concentration of 0.5 mg/mL in MeOH in the area 190&#x02013;400 nm; Figure S13: Comparison of <italic toggle="yes">mxc</italic> BGCs that have been characterized to produce different myxochelins in different myxobacterial strains and <italic toggle="yes">Pseudomonasalteromonas piscicida</italic>; Figure S14: Alternative producers of <bold>1</bold> from our in-house metabolome database sorted by suborder; Figure S15: High performance liquid chromatography&#x02013;mass spectrometry extracted ion chromatograms (HPLC&#x02013;MS EIC) of <bold>1</bold> orange ([M+H]<sup>+</sup> 504.1976 m/z, (orange), <bold>2</bold> ([M+H]<sup>+</sup> 404.1819 m/z, blue), and <bold>3</bold> ([M+H]<sup>+</sup> 405.1658 m/z, black) from the myxobacterial crude extracts of MCy9555, MCy10589, MCy9523 and MCy9472; Figure S16: <sup>1</sup>H NMR of compound <bold>1</bold>; Figure S17: <sup>1</sup>H NMR spectrum of compound <bold>1</bold> (expanded part 1); Figure S18: <sup>1</sup>H NMR spectrum of compound <bold>1</bold> (expanded part 2); Figure S19: <sup>13</sup>C NMR spectrum of compound <bold>1</bold>; Figure S20: <sup>1</sup>H-<sup>1</sup>H DQF-COSY spectrum of compound <bold>1</bold>; Figure S21: HSQC spectrum of compound <bold>1</bold>; Figure S22: HSQC spectrum of compound <bold>1</bold> (expanded); Figure S23: HSQC spectrum of compound <bold>1</bold> (expanded); Figure S24: <sup>1</sup>H-<sup>13</sup>C HMBC spectrum of compound <bold>1</bold>; Figure S25: <sup>1</sup>H-<sup>13</sup>C HMBC spectrum of compound <bold>1</bold> (expanded part 1); Figure S26: <sup>1</sup>H-<sup>13</sup>C HMBC spectrum of compound <bold>1</bold> (expanded part 2); Figure S27: <sup>1</sup>H-<sup>13</sup>C HMBC spectrum of compound <bold>1</bold> (expanded part 3); Figure S28: <sup>1</sup>H NMR spectrum of compound <bold>2</bold>.; Figure S29: <sup>1</sup>H NMR spectrum of compound <bold>2</bold> (expanded part 1); Figure S30: <sup>1</sup>H NMR spectrum of compound <bold>2</bold> (expanded part 2); Figure S31: <sup>13</sup>C NMR spectrum of compound <bold>2</bold> in MeOD; Figure S32: <sup>13</sup>C NMR spectrum of compound <bold>2</bold> (expanded part 1); Figure S33: <sup>13</sup>C NMR spectrum of compound <bold>2</bold> (expanded part 2); Figure S34: <sup>1</sup>H-<sup>1</sup>H DQF-COSY spectrum of compound <bold>2</bold>; Figure S35: <sup>1</sup>H-<sup>1</sup>H DQF-COSY spectrum of compound <bold>2</bold>; Figure S36: <sup>1</sup>H-<sup>1</sup>H DQF-COSY spectrum of compound <bold>2</bold> (expanded); Figure S37: HSQC spectrum of compound <bold>2</bold>; Figure S38: HSQC spectrum of compound <bold>2</bold> (expanded part 1); Figure S39: HSQC spectrum of compound <bold>2</bold> (expanded part 2); Figure S40: <sup>1</sup>H-<sup>13</sup>C HMBC spectrum of compound <bold>2</bold>; Figure S41: <sup>1</sup>H-<sup>13</sup>C HMBC spectrum of compound <bold>2</bold> (expanded part 1); Figure S42: <sup>1</sup>H-<sup>13</sup>C HMBC spectrum of compound <bold>2</bold> (expanded part 2); Figure S43: <sup>1</sup>H-<sup>13</sup>C HMBC spectrum of compound <bold>2</bold> (expanded part 3); Figure S44: <sup>1</sup>H-<sup>13</sup>C HMBC spectrum of compound <bold>2</bold> (expanded part 4); Figure S45: <sup>1</sup>H NMR spectrum of compound <bold>3</bold>; Figure S46: <sup>1</sup>H NMR spectrum of compound <bold>3</bold> (expanded part 1); Figure S47: <sup>1</sup>H NMR spectrum of compound <bold>3</bold> (expanded part 2); Figure S48: <sup>13</sup>C NMR spectrum of compound <bold>3</bold>; Figure S49: <sup>13</sup>C NMR spectrum of compound <bold>3</bold> (expanded part 1); Figure S50: <sup>13</sup>C NMR spectrum of compound <bold>3</bold> (expanded part 2); Figure S51: <sup>1</sup>H-<sup>1</sup>H DQF-COSY spectrum of compound <bold>3</bold>; Figure S52: <sup>1</sup>H-<sup>1</sup>H DQF-COSY spectrum of compound <bold>3</bold> (expanded part 1); Figure S53: <sup>1</sup>H-<sup>1</sup>H DQF-COSY spectrum of compound <bold>3</bold> (expanded part 2); Figure S54: HSQC spectrum of compound <bold>3</bold>; Figure S55: HSQC spectrum of compound <bold>3</bold> (expanded part 1); Figure S56: <sup>1</sup>H-<sup>1</sup>H DQF-COSY spectrum of compound <bold>3</bold> (expanded part 2); Figure S57: <sup>1</sup>H-<sup>13</sup>C HMBC spectrum of compound <bold>3</bold>; Figure S58: <sup>1</sup>H-<sup>13</sup>C HMBC spectrum of compound <bold>3</bold> (expanded part 1); Figure S59: <sup>1</sup>H-<sup>13</sup>C HMBC spectrum of compound <bold>3</bold> (expanded part 2); Figure S60: <sup>1</sup>H-<sup>13</sup>C HMBC spectrum of compound <bold>3</bold> (expanded part 3); Figure S61: <sup>1</sup>H-<sup>13</sup>C HMBC spectrum of compound <bold>3</bold> (expanded part 4); Table S1: Spectroscopic values of myxochelin B-succinate (<bold>1</bold>) acquired in CD<sub>3</sub>OD at 500 MHz; Table S2: Spectroscopic values of myxochelin B (<bold>2</bold>) acquired in CD<sub>3</sub>OD at 500 MHz; Table S3: Spectroscopic values of myxochelin A (<bold>3</bold>) acquired in CD<sub>3</sub>OD at 500 MHz; Table S4: Predicted functions of the encoded proteins by the Myxochelin BGC from MSr12020 (44350 bp). </p><supplementary-material id="microorganisms-10-01959-s001" position="float" content-type="local-data"><media xlink:href="microorganisms-10-01959-s001.zip"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></app></app-group><notes><title>Author Contributions</title><p>Conceptualization, D.A.O., J.J.H., R.G. and R.M.; formal analysis, D.A.O., J.J.H. and R.G.; investigation, D.A.O., J.J.H. and R.G.; resources, R.M.; data curation, D.A.O., J.J.H. and R.G.; writing&#x02014;original draft preparation, D.A.O., J.J.H. and R.G.; writing&#x02014;review and editing, D.A.O., J.J.H., R.G and R.M.; visualization, D.A.O., J.J.H. and R.G.; supervision, R.M.; project administration, R.M. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Institutional Review Board Statement</title><p>Not applicable.</p></notes><notes><title>Informed Consent Statement</title><p>Not applicable.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>All data presented in this study are available from the corresponding author on reasonable request.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-microorganisms-10-01959"><label>1.</label><element-citation publication-type="book"><person-group person-group-type="editor">
<name><surname>Crosa</surname><given-names>J.H.</given-names></name>
<name><surname>Mey</surname><given-names>A.R.</given-names></name>
<name><surname>Payne</surname><given-names>S.M.</given-names></name>
</person-group><source>Iron Transport in Bacteria</source><publisher-name>ASM Press</publisher-name><publisher-loc>Washington, DC, USA</publisher-loc><year>2004</year><isbn>9781683672050</isbn></element-citation></ref><ref id="B2-microorganisms-10-01959"><label>2.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Templeton</surname><given-names>D.</given-names></name>
</person-group><source>Molecular and Cellular Iron Transport</source><publisher-name>CRC Press</publisher-name><publisher-loc>Boca Raton, FL, USA</publisher-loc><year>2002</year><isbn>9780824744175</isbn></element-citation></ref><ref id="B3-microorganisms-10-01959"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Andrews</surname><given-names>S.C.</given-names></name>
<name><surname>Robinson</surname><given-names>A.K.</given-names></name>
<name><surname>Rodriguez-Quinones</surname><given-names>F.</given-names></name>
</person-group><article-title>Bacterial iron homeostasis</article-title><source>FEMS Microbiol. Rev.</source><year>2003</year><volume>27</volume><fpage>215</fpage><lpage>237</lpage><pub-id pub-id-type="doi">10.1016/S0168-6445(03)00055-X</pub-id><pub-id pub-id-type="pmid">12829269</pub-id></element-citation></ref><ref id="B4-microorganisms-10-01959"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kramer</surname><given-names>J.</given-names></name>
<name><surname>&#x000d6;zkaya</surname><given-names>&#x000d6;.</given-names></name>
<name><surname>K&#x000fc;mmerli</surname><given-names>R.</given-names></name>
</person-group><article-title>Bacterial siderophores in community and host interactions</article-title><source>Nat. Rev. Microbiol.</source><year>2020</year><volume>18</volume><fpage>152</fpage><lpage>163</lpage><pub-id pub-id-type="doi">10.1038/s41579-019-0284-4</pub-id><pub-id pub-id-type="pmid">31748738</pub-id></element-citation></ref><ref id="B5-microorganisms-10-01959"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sandy</surname><given-names>M.</given-names></name>
<name><surname>Butler</surname><given-names>A.</given-names></name>
</person-group><article-title>Microbial iron acquisition: Marine and terrestrial siderophores</article-title><source>Chem. Rev.</source><year>2009</year><volume>109</volume><fpage>4580</fpage><lpage>4595</lpage><pub-id pub-id-type="doi">10.1021/cr9002787</pub-id><pub-id pub-id-type="pmid">19772347</pub-id></element-citation></ref><ref id="B6-microorganisms-10-01959"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hider</surname><given-names>R.C.</given-names></name>
<name><surname>Kong</surname><given-names>X.</given-names></name>
</person-group><article-title>Chemistry and biology of siderophores</article-title><source>Nat. Prod. Rep.</source><year>2010</year><volume>27</volume><fpage>637</fpage><lpage>657</lpage><pub-id pub-id-type="doi">10.1039/b906679a</pub-id><?supplied-pmid 20376388?><pub-id pub-id-type="pmid">20376388</pub-id></element-citation></ref><ref id="B7-microorganisms-10-01959"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Barry</surname><given-names>S.M.</given-names></name>
<name><surname>Challis</surname><given-names>G.L.</given-names></name>
</person-group><article-title>Recent advances in siderophore biosynthesis</article-title><source>Curr. Opin. Chem. Biol.</source><year>2009</year><volume>13</volume><fpage>205</fpage><lpage>215</lpage><pub-id pub-id-type="doi">10.1016/j.cbpa.2009.03.008</pub-id><?supplied-pmid 19369113?><pub-id pub-id-type="pmid">19369113</pub-id></element-citation></ref><ref id="B8-microorganisms-10-01959"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Barona-Gomez</surname><given-names>F.</given-names></name>
<name><surname>Wong</surname><given-names>U.</given-names></name>
<name><surname>Giannakopulos</surname><given-names>A.E.</given-names></name>
<name><surname>Derrick</surname><given-names>P.J.</given-names></name>
<name><surname>Challis</surname><given-names>G.L.</given-names></name>
</person-group><article-title>Identification of a cluster of genes that directs desferrioxamine biosynthesis in <italic toggle="yes">Streptomyces coelicolor</italic> M145</article-title><source>J. Am. Chem. Soc.</source><year>2004</year><volume>126</volume><fpage>16282</fpage><lpage>16283</lpage><pub-id pub-id-type="doi">10.1021/ja045774k</pub-id><pub-id pub-id-type="pmid">15600304</pub-id></element-citation></ref><ref id="B9-microorganisms-10-01959"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Barona-Gomez</surname><given-names>F.</given-names></name>
<name><surname>Lautru</surname><given-names>S.</given-names></name>
<name><surname>Francou</surname><given-names>F.X.</given-names></name>
<name><surname>Leblond</surname><given-names>P.</given-names></name>
<name><surname>Pernodet</surname><given-names>J.L.</given-names></name>
<name><surname>Challis</surname><given-names>G.L.</given-names></name>
</person-group><article-title>Multiple biosynthetic and uptake systems mediate siderophore-dependent iron acquisition in <italic toggle="yes">Streptomyces coelicolor</italic> A3(2) and <italic toggle="yes">Streptomyces ambofaciens</italic> ATCC 23877</article-title><source>Microbiology</source><year>2006</year><volume>152</volume><fpage>3355</fpage><lpage>3366</lpage><pub-id pub-id-type="doi">10.1099/mic.0.29161-0</pub-id><?supplied-pmid 17074905?><pub-id pub-id-type="pmid">17074905</pub-id></element-citation></ref><ref id="B10-microorganisms-10-01959"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Schalk</surname><given-names>I.J.</given-names></name>
<name><surname>Rigouin</surname><given-names>C.</given-names></name>
<name><surname>Godet</surname><given-names>J.</given-names></name>
</person-group><article-title>An overview of siderophore biosynthesis among fluorescent Pseudomonads and new insights into their complex cellular organization</article-title><source>Environ. Microbiol.</source><year>2020</year><volume>22</volume><fpage>1447</fpage><lpage>1466</lpage><pub-id pub-id-type="doi">10.1111/1462-2920.14937</pub-id><pub-id pub-id-type="pmid">32011068</pub-id></element-citation></ref><ref id="B11-microorganisms-10-01959"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Munoz-Dorado</surname><given-names>J.</given-names></name>
<name><surname>Marcos-Torres</surname><given-names>F.J.</given-names></name>
<name><surname>Garcia-Bravo</surname><given-names>E.</given-names></name>
<name><surname>Moraleda-Munoz</surname><given-names>A.</given-names></name>
<name><surname>Perez</surname><given-names>J.</given-names></name>
</person-group><article-title>Myxobacteria: Moving, Killing, Feeding, and Surviving Together</article-title><source>Front. Microbiol.</source><year>2016</year><volume>7</volume><fpage>781</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2016.00781</pub-id><pub-id pub-id-type="pmid">27303375</pub-id></element-citation></ref><ref id="B12-microorganisms-10-01959"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Herrmann</surname><given-names>J.</given-names></name>
<name><surname>Fayad</surname><given-names>A.A.</given-names></name>
<name><surname>M&#x000fc;ller</surname><given-names>R.</given-names></name>
</person-group><article-title>Natural products from myxobacteria: Novel metabolites and bioactivities</article-title><source>Nat. Prod. Rep.</source><year>2017</year><volume>34</volume><fpage>135</fpage><lpage>160</lpage><pub-id pub-id-type="doi">10.1039/C6NP00106H</pub-id><pub-id pub-id-type="pmid">27907217</pub-id></element-citation></ref><ref id="B13-microorganisms-10-01959"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kunze</surname><given-names>B.</given-names></name>
<name><surname>Trowitzsch-Kienast</surname><given-names>W.</given-names></name>
<name><surname>H&#x000f6;fle</surname><given-names>G.</given-names></name>
<name><surname>Reichenbach</surname><given-names>H.</given-names></name>
</person-group><article-title>Nannochelins A, B and C, new iron-chelating compounds from <italic toggle="yes">Nannocystis exedens</italic> (myxobacteria). Production, isolation, physico-chemical and biological properties</article-title><source>J. Antibiot.</source><year>1992</year><volume>45</volume><fpage>147</fpage><lpage>150</lpage><pub-id pub-id-type="doi">10.7164/antibiotics.45.147</pub-id><?supplied-pmid 1556005?><pub-id pub-id-type="pmid">1556005</pub-id></element-citation></ref><ref id="B14-microorganisms-10-01959"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nadmid</surname><given-names>S.</given-names></name>
<name><surname>Plaza</surname><given-names>A.</given-names></name>
<name><surname>Lauro</surname><given-names>G.</given-names></name>
<name><surname>Garcia</surname><given-names>R.</given-names></name>
<name><surname>Bifulco</surname><given-names>G.</given-names></name>
<name><surname>M&#x000fc;ller</surname><given-names>R.</given-names></name>
</person-group><article-title>Hyalachelins A-C, unusual siderophores isolated from the terrestrial myxobacterium <italic toggle="yes">Hyalangium minutum</italic></article-title><source>Org. Lett.</source><year>2014</year><volume>16</volume><fpage>4130</fpage><lpage>4133</lpage><pub-id pub-id-type="doi">10.1021/ol501826a</pub-id><?supplied-pmid 25058569?><pub-id pub-id-type="pmid">25058569</pub-id></element-citation></ref><ref id="B15-microorganisms-10-01959"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kunze</surname><given-names>B.</given-names></name>
<name><surname>Bedorf</surname><given-names>N.</given-names></name>
<name><surname>Kohl</surname><given-names>W.</given-names></name>
<name><surname>H&#x000f6;fle</surname><given-names>G.</given-names></name>
<name><surname>Reichenbach</surname><given-names>H.</given-names></name>
</person-group><article-title>Myxochelin A, a new iron-chelating compound from <italic toggle="yes">Angiococcus disciformis</italic> (Myxobacterales). Production, isolation, physico-chemical and biological properties</article-title><source>J. Antibiot.</source><year>1989</year><volume>42</volume><fpage>14</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.7164/antibiotics.42.14</pub-id><?supplied-pmid 2493439?><pub-id pub-id-type="pmid">2493439</pub-id></element-citation></ref><ref id="B16-microorganisms-10-01959"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ambrosi</surname><given-names>H.D.</given-names></name>
<name><surname>Hartmann</surname><given-names>V.</given-names></name>
<name><surname>Pistorius</surname><given-names>D.</given-names></name>
<name><surname>Reissbrodt</surname><given-names>R.</given-names></name>
<name><surname>Trowitzsch-Kienast</surname><given-names>W.</given-names></name>
</person-group><article-title>Myxochelins B, C, D, E and F: A new structural principle for powerful siderophores imitating nature</article-title><source>Eur. J. Org. Chem.</source><year>1998</year><fpage>541</fpage><lpage>551</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1099-0690(199803)1998:3&#x0003c;541::AID-EJOC541&#x0003e;3.0.CO;2-A</pub-id></element-citation></ref><ref id="B17-microorganisms-10-01959"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Frank</surname><given-names>N.A.</given-names></name>
<name><surname>Sz&#x000e9;les</surname><given-names>M.</given-names></name>
<name><surname>Akone</surname><given-names>S.H.</given-names></name>
<name><surname>Rasheed</surname><given-names>S.</given-names></name>
<name><surname>H&#x000fc;ttel</surname><given-names>S.</given-names></name>
<name><surname>Frewert</surname><given-names>S.</given-names></name>
<name><surname>Hamed</surname><given-names>M.M.</given-names></name>
<name><surname>Herrmann</surname><given-names>J.</given-names></name>
<name><surname>Schuler</surname><given-names>S.M.M.</given-names></name>
<name><surname>Hirsch</surname><given-names>A.K.H.</given-names></name>
<etal/>
</person-group><article-title>Expanding the Myxochelin Natural Product Family by Nicotinic Acid Containing Congeners</article-title><source>Molecules</source><year>2021</year><volume>26</volume><elocation-id>4929</elocation-id><pub-id pub-id-type="doi">10.3390/molecules26164929</pub-id><pub-id pub-id-type="pmid">34443518</pub-id></element-citation></ref><ref id="B18-microorganisms-10-01959"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gaitatzis</surname><given-names>N.</given-names></name>
<name><surname>Kunze</surname><given-names>B.</given-names></name>
<name><surname>M&#x000fc;ller</surname><given-names>R.</given-names></name>
</person-group><article-title>In vitro reconstitution of the myxochelin biosynthetic machinery of <italic toggle="yes">Stigmatella aurantiaca</italic> Sg a15: Biochemical characterization of a reductive release mechanism from nonribosomal peptide synthetases</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2001</year><volume>98</volume><fpage>11136</fpage><lpage>11141</lpage><pub-id pub-id-type="doi">10.1073/pnas.201167098</pub-id><pub-id pub-id-type="pmid">11562468</pub-id></element-citation></ref><ref id="B19-microorganisms-10-01959"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Li</surname><given-names>Y.</given-names></name>
<name><surname>Weissman</surname><given-names>K.J.</given-names></name>
<name><surname>M&#x000fc;ller</surname><given-names>R.</given-names></name>
</person-group><article-title>Myxochelin biosynthesis: Direct evidence for two- and four-electron reduction of a carrier protein-bound thioester</article-title><source>J. Am. Chem. Soc.</source><year>2008</year><volume>130</volume><fpage>7554</fpage><lpage>7555</lpage><pub-id pub-id-type="doi">10.1021/ja8025278</pub-id><pub-id pub-id-type="pmid">18498160</pub-id></element-citation></ref><ref id="B20-microorganisms-10-01959"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Silakowski</surname><given-names>B.</given-names></name>
<name><surname>Kunze</surname><given-names>B.</given-names></name>
<name><surname>Nordsiek</surname><given-names>G.</given-names></name>
<name><surname>Bl&#x000f6;cker</surname><given-names>H.</given-names></name>
<name><surname>H&#x000f6;fle</surname><given-names>G.</given-names></name>
<name><surname>M&#x000fc;ller</surname><given-names>R.</given-names></name>
</person-group><article-title>The myxochelin iron transport regulon of the myxobacterium <italic toggle="yes">Stigmatella aurantiaca</italic> Sg a15</article-title><source>Eur. J. Biochem.</source><year>2000</year><volume>267</volume><fpage>6476</fpage><lpage>6485</lpage><pub-id pub-id-type="doi">10.1046/j.1432-1327.2000.01740.x</pub-id><pub-id pub-id-type="pmid">11029592</pub-id></element-citation></ref><ref id="B21-microorganisms-10-01959"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gaitatzis</surname><given-names>N.</given-names></name>
<name><surname>Kunze</surname><given-names>B.</given-names></name>
<name><surname>M&#x000fc;ller</surname><given-names>R.</given-names></name>
</person-group><article-title>Novel insights into siderophore formation in myxobacteria</article-title><source>ChemBioChem</source><year>2005</year><volume>6</volume><fpage>365</fpage><lpage>374</lpage><pub-id pub-id-type="doi">10.1002/cbic.200400206</pub-id><pub-id pub-id-type="pmid">15678426</pub-id></element-citation></ref><ref id="B22-microorganisms-10-01959"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Krug</surname><given-names>D.</given-names></name>
<name><surname>Zurek</surname><given-names>G.</given-names></name>
<name><surname>Revermann</surname><given-names>O.</given-names></name>
<name><surname>Vos</surname><given-names>M.</given-names></name>
<name><surname>Velicer</surname><given-names>G.J.</given-names></name>
<name><surname>M&#x000fc;ller</surname><given-names>R.</given-names></name>
</person-group><article-title>Discovering the Hidden Secondary Metabolome of <italic toggle="yes">Myxococcus xanthus</italic>: A Study of Intraspecific Diversity</article-title><source>Appl. Environ. Microbiol.</source><year>2008</year><volume>74</volume><fpage>3058</fpage><lpage>3068</lpage><pub-id pub-id-type="doi">10.1128/AEM.02863-07</pub-id><pub-id pub-id-type="pmid">18378661</pub-id></element-citation></ref><ref id="B23-microorganisms-10-01959"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kim</surname><given-names>J.</given-names></name>
<name><surname>Choi</surname><given-names>J.N.</given-names></name>
<name><surname>Kim</surname><given-names>P.</given-names></name>
<name><surname>Sok</surname><given-names>D.E.</given-names></name>
<name><surname>Nam</surname><given-names>S.W.</given-names></name>
<name><surname>Lee</surname><given-names>C.H.</given-names></name>
</person-group><article-title>LC-MS/MS Profiling-Based Secondary Metabolite Screening of <italic toggle="yes">Myxococcus xanthus</italic></article-title><source>J. Microbiol. Biotechnol.</source><year>2009</year><volume>19</volume><fpage>51</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.4014/jmb.0711</pub-id><?supplied-pmid 19190408?><pub-id pub-id-type="pmid">19190408</pub-id></element-citation></ref><ref id="B24-microorganisms-10-01959"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Miyanaga</surname><given-names>S.</given-names></name>
<name><surname>Obata</surname><given-names>T.</given-names></name>
<name><surname>Onaka</surname><given-names>H.</given-names></name>
<name><surname>Fujita</surname><given-names>T.</given-names></name>
<name><surname>Saito</surname><given-names>N.</given-names></name>
<name><surname>Sakurai</surname><given-names>H.</given-names></name>
<name><surname>Saiki</surname><given-names>I.</given-names></name>
<name><surname>Furumai</surname><given-names>T.</given-names></name>
<name><surname>Igarashi</surname><given-names>Y.</given-names></name>
</person-group><article-title>Absolute configuration and antitumor activity of myxochelin A produced by <italic toggle="yes">Nonomuraea pusilla</italic> TP-A0861</article-title><source>J. Antibiot.</source><year>2006</year><volume>59</volume><fpage>698</fpage><lpage>703</lpage><pub-id pub-id-type="doi">10.1038/ja.2006.93</pub-id><?supplied-pmid 17256468?><pub-id pub-id-type="pmid">17256468</pub-id></element-citation></ref><ref id="B25-microorganisms-10-01959"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bitok</surname><given-names>J.K.</given-names></name>
<name><surname>Lemetre</surname><given-names>C.</given-names></name>
<name><surname>Ternei</surname><given-names>M.A.</given-names></name>
<name><surname>Brady</surname><given-names>S.F.</given-names></name>
</person-group><article-title>Identification of biosynthetic gene clusters from metagenomic libraries using PPTase complementation in a <italic toggle="yes">Streptomyces</italic> host</article-title><source>FEMS Microbiol. Lett.</source><year>2017</year><volume>364</volume><fpage>fnx155</fpage><pub-id pub-id-type="doi">10.1093/femsle/fnx155</pub-id></element-citation></ref><ref id="B26-microorganisms-10-01959"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kiss</surname><given-names>H.</given-names></name>
<name><surname>Nett</surname><given-names>M.</given-names></name>
<name><surname>Domin</surname><given-names>N.</given-names></name>
<name><surname>Martin</surname><given-names>K.</given-names></name>
<name><surname>Maresca</surname><given-names>J.A.</given-names></name>
<name><surname>Copeland</surname><given-names>A.</given-names></name>
<name><surname>Lapidus</surname><given-names>A.</given-names></name>
<name><surname>Lucas</surname><given-names>S.</given-names></name>
<name><surname>Berry</surname><given-names>K.W.</given-names></name>
<name><surname>Glavina Del Rio</surname><given-names>T.</given-names></name>
<etal/>
</person-group><article-title>Complete genome sequence of the filamentous gliding predatory bacterium <italic toggle="yes">Herpetosiphon aurantiacus</italic> type strain (114-95<sup>T</sup>)</article-title><source>Stand. Genom. Sci.</source><year>2011</year><volume>5</volume><fpage>356</fpage><lpage>370</lpage><pub-id pub-id-type="doi">10.4056/sigs.2194987</pub-id><?supplied-pmid 22675585?><pub-id pub-id-type="pmid">22675585</pub-id></element-citation></ref><ref id="B27-microorganisms-10-01959"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sonnenschein</surname><given-names>E.C.</given-names></name>
<name><surname>Stierhof</surname><given-names>M.</given-names></name>
<name><surname>Goralczyk</surname><given-names>S.</given-names></name>
<name><surname>Vabre</surname><given-names>F.M.</given-names></name>
<name><surname>Pellissier</surname><given-names>L.</given-names></name>
<name><surname>Hanssen</surname><given-names>K.&#x000d8;.</given-names></name>
<name><surname>La Cruz</surname><given-names>M.d.</given-names></name>
<name><surname>D&#x000ed;az</surname><given-names>C.</given-names></name>
<name><surname>Witte</surname><given-names>P.d.</given-names></name>
<name><surname>Copmans</surname><given-names>D.</given-names></name>
<etal/>
</person-group><article-title>Pseudochelin A, a siderophore of <italic toggle="yes">Pseudoalteromonas piscicida</italic> S2040</article-title><source>Tetrahedron</source><year>2017</year><volume>73</volume><fpage>2633</fpage><lpage>2637</lpage><pub-id pub-id-type="doi">10.1016/j.tet.2017.03.051</pub-id></element-citation></ref><ref id="B28-microorganisms-10-01959"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Miyanaga</surname><given-names>S.</given-names></name>
<name><surname>Sakurai</surname><given-names>H.</given-names></name>
<name><surname>Saiki</surname><given-names>I.</given-names></name>
<name><surname>Onaka</surname><given-names>H.</given-names></name>
<name><surname>Igarashi</surname><given-names>Y.</given-names></name>
</person-group><article-title>Synthesis and evaluation of myxochelin analogues as antimetastatic agents</article-title><source>Bioorg. Med. Chem.</source><year>2009</year><volume>17</volume><fpage>2724</fpage><lpage>2732</lpage><pub-id pub-id-type="doi">10.1016/j.bmc.2009.02.040</pub-id><pub-id pub-id-type="pmid">19282185</pub-id></element-citation></ref><ref id="B29-microorganisms-10-01959"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Korp</surname><given-names>J.</given-names></name>
<name><surname>K&#x000f6;nig</surname><given-names>S.</given-names></name>
<name><surname>Schieferdecker</surname><given-names>S.</given-names></name>
<name><surname>Dahse</surname><given-names>H.-M.</given-names></name>
<name><surname>K&#x000f6;nig</surname><given-names>G.M.</given-names></name>
<name><surname>Werz</surname><given-names>O.</given-names></name>
<name><surname>Nett</surname><given-names>M.</given-names></name>
</person-group><article-title>Harnessing Enzymatic Promiscuity in Myxochelin Biosynthesis for the Production of 5-Lipoxygenase Inhibitors</article-title><source>ChemBioChem</source><year>2015</year><volume>16</volume><fpage>2445</fpage><lpage>2450</lpage><pub-id pub-id-type="doi">10.1002/cbic.201500446</pub-id><pub-id pub-id-type="pmid">26416255</pub-id></element-citation></ref><ref id="B30-microorganisms-10-01959"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Balouiri</surname><given-names>M.</given-names></name>
<name><surname>Sadiki</surname><given-names>M.</given-names></name>
<name><surname>Ibnsouda</surname><given-names>S.K.</given-names></name>
</person-group><article-title>Methods for in vitro evaluating antimicrobial activity: A review</article-title><source>J. Pharm. Anal.</source><year>2016</year><volume>6</volume><fpage>71</fpage><lpage>79</lpage><pub-id pub-id-type="doi">10.1016/j.jpha.2015.11.005</pub-id><pub-id pub-id-type="pmid">29403965</pub-id></element-citation></ref><ref id="B31-microorganisms-10-01959"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>D.-G.</given-names></name>
<name><surname>Niu</surname><given-names>L.</given-names></name>
<name><surname>Lin</surname><given-names>Z.-M.</given-names></name>
<name><surname>Wang</surname><given-names>J.-J.</given-names></name>
<name><surname>Gao</surname><given-names>D.-F.</given-names></name>
<name><surname>Sui</surname><given-names>H.-Y.</given-names></name>
<name><surname>Li</surname><given-names>Y.-Z.</given-names></name>
<name><surname>Wu</surname><given-names>C.</given-names></name>
</person-group><article-title>The Discovery and Biosynthesis of Nicotinic Myxochelins from an <italic toggle="yes">Archangium</italic> sp. SDU34</article-title><source>J. Nat. Prod.</source><year>2021</year><volume>84</volume><fpage>2744</fpage><lpage>2748</lpage><pub-id pub-id-type="doi">10.1021/acs.jnatprod.1c00524</pub-id><pub-id pub-id-type="pmid">34623817</pub-id></element-citation></ref><ref id="B32-microorganisms-10-01959"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bennett</surname><given-names>B.D.</given-names></name>
<name><surname>Kimball</surname><given-names>E.H.</given-names></name>
<name><surname>Gao</surname><given-names>M.</given-names></name>
<name><surname>Osterhout</surname><given-names>R.</given-names></name>
<name><surname>van Dien</surname><given-names>S.J.</given-names></name>
<name><surname>Rabinowitz</surname><given-names>J.D.</given-names></name>
</person-group><article-title>Absolute metabolite concentrations and implied enzyme active site occupancy in <italic toggle="yes">Escherichia coli</italic></article-title><source>Nat. Chem. Biol.</source><year>2009</year><volume>5</volume><fpage>593</fpage><lpage>599</lpage><pub-id pub-id-type="doi">10.1038/nchembio.186</pub-id><pub-id pub-id-type="pmid">19561621</pub-id></element-citation></ref><ref id="B33-microorganisms-10-01959"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Simon</surname><given-names>E.J.</given-names></name>
<name><surname>Shemin</surname><given-names>D.</given-names></name>
</person-group><article-title>The Preparation of S-Succinyl Coenzyme A</article-title><source>Adv. Ceram. Mater.</source><year>1953</year><volume>75</volume><fpage>2520</fpage><pub-id pub-id-type="doi">10.1021/ja01106a522</pub-id></element-citation></ref><ref id="B34-microorganisms-10-01959"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Okoth</surname><given-names>D.A.</given-names></name>
<name><surname>Hug</surname><given-names>J.J.</given-names></name>
<name><surname>M&#x000e1;ndi</surname><given-names>A.</given-names></name>
<name><surname>Kurt&#x000e1;n</surname><given-names>T.</given-names></name>
<name><surname>Garcia</surname><given-names>R.</given-names></name>
<name><surname>M&#x000fc;ller</surname><given-names>R.</given-names></name>
</person-group><article-title>Structure and biosynthesis of sorangipyranone&#x02014;A new &#x003b3;-dihydropyrone from the myxobacterial strain MSr12020</article-title><source>J. Ind. Microbiol.</source><year>2021</year><volume>48</volume><fpage>kuab029</fpage><pub-id pub-id-type="doi">10.1093/jimb/kuab029</pub-id><?supplied-pmid 34003283?><pub-id pub-id-type="pmid">34003283</pub-id></element-citation></ref><ref id="B35-microorganisms-10-01959"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Blin</surname><given-names>K.</given-names></name>
<name><surname>Shaw</surname><given-names>S.</given-names></name>
<name><surname>Kloosterman</surname><given-names>A.M.</given-names></name>
<name><surname>Charlop-Powers</surname><given-names>Z.</given-names></name>
<name><surname>van Wezel</surname><given-names>G.P.</given-names></name>
<name><surname>Medema</surname><given-names>M.H.</given-names></name>
<name><surname>Weber</surname><given-names>T.</given-names></name>
</person-group><article-title>antiSMASH 6.0: Improving cluster detection and comparison capabilities</article-title><source>Nucleic Acids Res.</source><year>2021</year><volume>49</volume><fpage>W29</fpage><lpage>W35</lpage><pub-id pub-id-type="doi">10.1093/nar/gkab335</pub-id><?supplied-pmid 33978755?><pub-id pub-id-type="pmid">33978755</pub-id></element-citation></ref><ref id="B36-microorganisms-10-01959"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kearse</surname><given-names>M.</given-names></name>
<name><surname>Moir</surname><given-names>R.</given-names></name>
<name><surname>Wilson</surname><given-names>A.</given-names></name>
<name><surname>Stones-Havas</surname><given-names>S.</given-names></name>
<name><surname>Cheung</surname><given-names>M.</given-names></name>
<name><surname>Sturrock</surname><given-names>S.</given-names></name>
<name><surname>Buxton</surname><given-names>S.</given-names></name>
<name><surname>Cooper</surname><given-names>A.</given-names></name>
<name><surname>Markowitz</surname><given-names>S.</given-names></name>
<name><surname>Duran</surname><given-names>C.</given-names></name>
<etal/>
</person-group><article-title>Geneious Basic: An integrated and extendable desktop software platform for the organization and analysis of sequence data</article-title><source>Bioinformatics</source><year>2012</year><volume>28</volume><fpage>1647</fpage><lpage>1649</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/bts199</pub-id><?supplied-pmid 22543367?><pub-id pub-id-type="pmid">22543367</pub-id></element-citation></ref><ref id="B37-microorganisms-10-01959"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mistry</surname><given-names>J.</given-names></name>
<name><surname>Chuguransky</surname><given-names>S.</given-names></name>
<name><surname>Williams</surname><given-names>L.</given-names></name>
<name><surname>Qureshi</surname><given-names>M.</given-names></name>
<name><surname>Salazar</surname><given-names>G.A.</given-names></name>
<name><surname>Sonnhammer</surname><given-names>E.L.L.</given-names></name>
<name><surname>Tosatto</surname><given-names>S.C.E.</given-names></name>
<name><surname>Paladin</surname><given-names>L.</given-names></name>
<name><surname>Raj</surname><given-names>S.</given-names></name>
<name><surname>Richardson</surname><given-names>L.J.</given-names></name>
<etal/>
</person-group><article-title>Pfam: The protein families database in 2021</article-title><source>Nucleic Acids Res.</source><year>2021</year><volume>49</volume><fpage>D412</fpage><lpage>D419</lpage><pub-id pub-id-type="doi">10.1093/nar/gkaa913</pub-id><?supplied-pmid 33125078?><pub-id pub-id-type="pmid">33125078</pub-id></element-citation></ref><ref id="B38-microorganisms-10-01959"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kelley</surname><given-names>L.A.</given-names></name>
<name><surname>Mezulis</surname><given-names>S.</given-names></name>
<name><surname>Yates</surname><given-names>C.M.</given-names></name>
<name><surname>Wass</surname><given-names>M.N.</given-names></name>
<name><surname>Sternberg</surname><given-names>M.J.E.</given-names></name>
</person-group><article-title>The Phyre2 web portal for protein modeling, prediction and analysis</article-title><source>Nat. Protoc.</source><year>2015</year><volume>10</volume><fpage>845</fpage><lpage>858</lpage><pub-id pub-id-type="doi">10.1038/nprot.2015.053</pub-id><pub-id pub-id-type="pmid">25950237</pub-id></element-citation></ref><ref id="B39-microorganisms-10-01959"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hoffmann</surname><given-names>T.</given-names></name>
<name><surname>Krug</surname><given-names>D.</given-names></name>
<name><surname>Bozkurt</surname><given-names>N.</given-names></name>
<name><surname>Duddela</surname><given-names>S.</given-names></name>
<name><surname>Jansen</surname><given-names>R.</given-names></name>
<name><surname>Garcia</surname><given-names>R.</given-names></name>
<name><surname>Gerth</surname><given-names>K.</given-names></name>
<name><surname>Steinmetz</surname><given-names>H.</given-names></name>
<name><surname>M&#x000fc;ller</surname><given-names>R.</given-names></name>
</person-group><article-title>Correlating chemical diversity with taxonomic distance for discovery of natural products in myxobacteria</article-title><source>Nat. Commun.</source><year>2018</year><volume>9</volume><fpage>803</fpage><pub-id pub-id-type="doi">10.1038/s41467-018-03184-1</pub-id><pub-id pub-id-type="pmid">29476047</pub-id></element-citation></ref><ref id="B40-microorganisms-10-01959"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ahn</surname><given-names>J.-W.</given-names></name>
<name><surname>Lee</surname><given-names>C.-O.</given-names></name>
<name><surname>Baek</surname><given-names>S.-H.</given-names></name>
</person-group><article-title>Myxochelin A, a cytotoxic antibiotic from the myxobacterium <italic toggle="yes">Angiococcus disciformis</italic></article-title><source>Orient. Pharm. Exp. Med.</source><year>2002</year><volume>2</volume><fpage>64</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.3742/OPEM.2002.2.1.064</pub-id></element-citation></ref><ref id="B41-microorganisms-10-01959"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Corbin</surname><given-names>J.L.</given-names></name>
<name><surname>Bulen</surname><given-names>W.A.</given-names></name>
</person-group><article-title>The isolation and identification of 2,3-dihydroxybenzoic acid and 2-<italic toggle="yes">N</italic>,6-<italic toggle="yes">N</italic>-di-92,3-dihydroxybenzoyl)-L-lysine formed by iron-deficient <italic toggle="yes">Azotobacter vinelandii</italic></article-title><source>Biochemistry</source><year>1969</year><volume>8</volume><fpage>757</fpage><lpage>762</lpage><pub-id pub-id-type="doi">10.1021/bi00831a002</pub-id><pub-id pub-id-type="pmid">5781016</pub-id></element-citation></ref><ref id="B42-microorganisms-10-01959"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sester</surname><given-names>A.</given-names></name>
<name><surname>Winand</surname><given-names>L.</given-names></name>
<name><surname>Pace</surname><given-names>S.</given-names></name>
<name><surname>Hiller</surname><given-names>W.</given-names></name>
<name><surname>Werz</surname><given-names>O.</given-names></name>
<name><surname>Nett</surname><given-names>M.</given-names></name>
</person-group><article-title>Myxochelin- and Pseudochelin-Derived Lipoxygenase Inhibitors from a Genetically Engineered <italic toggle="yes">Myxococcus xanthus</italic> Strain</article-title><source>J. Nat. Prod.</source><year>2019</year><volume>82</volume><fpage>2544</fpage><lpage>2549</lpage><pub-id pub-id-type="doi">10.1021/acs.jnatprod.9b00403</pub-id><pub-id pub-id-type="pmid">31465225</pub-id></element-citation></ref><ref id="B43-microorganisms-10-01959"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sinha</surname><given-names>S.</given-names></name>
<name><surname>Doble</surname><given-names>M.</given-names></name>
<name><surname>Manju</surname><given-names>S.L.</given-names></name>
</person-group><article-title>5-Lipoxygenase as a drug target: A review on trends in inhibitors structural design, SAR and mechanism based approach</article-title><source>Bioorg. Med. Chem.</source><year>2019</year><volume>27</volume><fpage>3745</fpage><lpage>3759</lpage><pub-id pub-id-type="doi">10.1016/j.bmc.2019.06.040</pub-id><pub-id pub-id-type="pmid">31331653</pub-id></element-citation></ref><ref id="B44-microorganisms-10-01959"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Schieferdecker</surname><given-names>S.</given-names></name>
<name><surname>K&#x000f6;nig</surname><given-names>S.</given-names></name>
<name><surname>Koeberle</surname><given-names>A.</given-names></name>
<name><surname>Dahse</surname><given-names>H.-M.</given-names></name>
<name><surname>Werz</surname><given-names>O.</given-names></name>
<name><surname>Nett</surname><given-names>M.</given-names></name>
</person-group><article-title>Myxochelins target human 5-lipoxygenase</article-title><source>J. Nat. Prod.</source><year>2015</year><volume>78</volume><fpage>335</fpage><lpage>338</lpage><pub-id pub-id-type="doi">10.1021/np500909b</pub-id><?supplied-pmid 25686392?><pub-id pub-id-type="pmid">25686392</pub-id></element-citation></ref><ref id="B45-microorganisms-10-01959"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Schieferdecker</surname><given-names>S.</given-names></name>
<name><surname>K&#x000f6;nig</surname><given-names>S.</given-names></name>
<name><surname>Pace</surname><given-names>S.</given-names></name>
<name><surname>Werz</surname><given-names>O.</given-names></name>
<name><surname>Nett</surname><given-names>M.</given-names></name>
</person-group><article-title>Myxochelin-Inspired 5-Lipoxygenase Inhibitors: Synthesis and Biological Evaluation</article-title><source>ChemMedChem</source><year>2017</year><volume>12</volume><fpage>23</fpage><lpage>27</lpage><pub-id pub-id-type="doi">10.1002/cmdc.201600536</pub-id><?supplied-pmid 27875023?><pub-id pub-id-type="pmid">27875023</pub-id></element-citation></ref><ref id="B46-microorganisms-10-01959"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wagner</surname><given-names>G.R.</given-names></name>
<name><surname>Payne</surname><given-names>R.M.</given-names></name>
</person-group><article-title>Widespread and enzyme-independent N&#x003b5;-acetylation and <italic toggle="yes">N</italic><sup>&#x003b5;</sup>-succinylation of proteins in the chemical conditions of the mitochondrial matrix</article-title><source>J. Biol. Chem.</source><year>2013</year><volume>288</volume><fpage>29036</fpage><lpage>29045</lpage><pub-id pub-id-type="doi">10.1074/jbc.M113.486753</pub-id><?supplied-pmid 23946487?><pub-id pub-id-type="pmid">23946487</pub-id></element-citation></ref><ref id="B47-microorganisms-10-01959"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>&#x0015a;mia&#x00142;ek</surname><given-names>J.</given-names></name>
<name><surname>Nowakowski</surname><given-names>M.</given-names></name>
<name><surname>Bzowska</surname><given-names>M.</given-names></name>
<name><surname>Boche&#x00144;ska</surname><given-names>O.</given-names></name>
<name><surname>Wliz&#x00142;o</surname><given-names>A.</given-names></name>
<name><surname>Kozik</surname><given-names>A.</given-names></name>
<name><surname>Dubin</surname><given-names>G.</given-names></name>
<name><surname>Mak</surname><given-names>P.</given-names></name>
</person-group><article-title>Structure, Biosynthesis, and Biological Activity of Succinylated Forms of Bacteriocin BacSp222</article-title><source>Int. J. Mol. Sci.</source><year>2021</year><volume>22</volume><elocation-id>6256</elocation-id><pub-id pub-id-type="doi">10.3390/ijms22126256</pub-id><?supplied-pmid 34200765?><pub-id pub-id-type="pmid">34200765</pub-id></element-citation></ref><ref id="B48-microorganisms-10-01959"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Phan</surname><given-names>T.B.</given-names></name>
<name><surname>Breugst</surname><given-names>M.</given-names></name>
<name><surname>Mayr</surname><given-names>H.</given-names></name>
</person-group><article-title>Towards a general scale of nucleophilicity?</article-title><source>Angew. Chem. Int. Ed.</source><year>2006</year><volume>45</volume><fpage>3869</fpage><lpage>3874</lpage><pub-id pub-id-type="doi">10.1002/anie.200600542</pub-id></element-citation></ref><ref id="B49-microorganisms-10-01959"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wagner</surname><given-names>G.R.</given-names></name>
<name><surname>Bhatt</surname><given-names>D.P.</given-names></name>
<name><surname>O&#x02019;Connell</surname><given-names>T.M.</given-names></name>
<name><surname>Thompson</surname><given-names>J.W.</given-names></name>
<name><surname>Dubois</surname><given-names>L.G.</given-names></name>
<name><surname>Backos</surname><given-names>D.S.</given-names></name>
<name><surname>Yang</surname><given-names>H.</given-names></name>
<name><surname>Mitchell</surname><given-names>G.A.</given-names></name>
<name><surname>Ilkayeva</surname><given-names>O.R.</given-names></name>
<name><surname>Stevens</surname><given-names>R.D.</given-names></name>
<etal/>
</person-group><article-title>A Class of Reactive Acyl-CoA Species Reveals the Non-enzymatic Origins of Protein Acylation</article-title><source>Cell Metab.</source><year>2017</year><volume>25</volume><fpage>823</fpage><lpage>837.e8</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2017.03.006</pub-id><?supplied-pmid 28380375?><pub-id pub-id-type="pmid">28380375</pub-id></element-citation></ref><ref id="B50-microorganisms-10-01959"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Weinert</surname><given-names>B.T.</given-names></name>
<name><surname>Sch&#x000f6;lz</surname><given-names>C.</given-names></name>
<name><surname>Wagner</surname><given-names>S.A.</given-names></name>
<name><surname>Iesmantavicius</surname><given-names>V.</given-names></name>
<name><surname>Su</surname><given-names>D.</given-names></name>
<name><surname>Daniel</surname><given-names>J.A.</given-names></name>
<name><surname>Choudhary</surname><given-names>C.</given-names></name>
</person-group><article-title>Lysine succinylation is a frequently occurring modification in prokaryotes and eukaryotes and extensively overlaps with acetylation</article-title><source>Cell Rep.</source><year>2013</year><volume>4</volume><fpage>842</fpage><lpage>851</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2013.07.024</pub-id><?supplied-pmid 23954790?><pub-id pub-id-type="pmid">23954790</pub-id></element-citation></ref><ref id="B51-microorganisms-10-01959"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>Z.</given-names></name>
<name><surname>Tan</surname><given-names>M.</given-names></name>
<name><surname>Xie</surname><given-names>Z.</given-names></name>
<name><surname>Dai</surname><given-names>L.</given-names></name>
<name><surname>Chen</surname><given-names>Y.</given-names></name>
<name><surname>Zhao</surname><given-names>Y.</given-names></name>
</person-group><article-title>Identification of lysine succinylation as a new post-translational modification</article-title><source>Nat. Chem. Biol.</source><year>2011</year><volume>7</volume><fpage>58</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1038/nchembio.495</pub-id><?supplied-pmid 21151122?><pub-id pub-id-type="pmid">21151122</pub-id></element-citation></ref><ref id="B52-microorganisms-10-01959"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bochmann</surname><given-names>S.M.</given-names></name>
<name><surname>Spie&#x000df;</surname><given-names>T.</given-names></name>
<name><surname>K&#x000f6;tter</surname><given-names>P.</given-names></name>
<name><surname>Entian</surname><given-names>K.-D.</given-names></name>
</person-group><article-title>Synthesis and succinylation of subtilin-like lantibiotics are strongly influenced by glucose and transition state regulator AbrB</article-title><source>Appl. Environ. Microbiol.</source><year>2015</year><volume>81</volume><fpage>614</fpage><lpage>622</lpage><pub-id pub-id-type="doi">10.1128/AEM.02579-14</pub-id><pub-id pub-id-type="pmid">25381239</pub-id></element-citation></ref><ref id="B53-microorganisms-10-01959"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cochrane</surname><given-names>S.A.</given-names></name>
<name><surname>Surgenor</surname><given-names>R.R.</given-names></name>
<name><surname>Khey</surname><given-names>K.M.W.</given-names></name>
<name><surname>Vederas</surname><given-names>J.C.</given-names></name>
</person-group><article-title>Total Synthesis and Stereochemical Assignment of the Antimicrobial Lipopeptide Cerexin A1</article-title><source>Org. Lett.</source><year>2015</year><volume>17</volume><fpage>5428</fpage><lpage>5431</lpage><pub-id pub-id-type="doi">10.1021/acs.orglett.5b02779</pub-id><?supplied-pmid 26465807?><pub-id pub-id-type="pmid">26465807</pub-id></element-citation></ref><ref id="B54-microorganisms-10-01959"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Li</surname><given-names>Z.</given-names></name>
<name><surname>Vries</surname><given-names>R.H.d.</given-names></name>
<name><surname>Chakraborty</surname><given-names>P.</given-names></name>
<name><surname>Song</surname><given-names>C.</given-names></name>
<name><surname>Zhao</surname><given-names>X.</given-names></name>
<name><surname>Scheffers</surname><given-names>D.-J.</given-names></name>
<name><surname>Roelfes</surname><given-names>G.</given-names></name>
<name><surname>Kuipers</surname><given-names>O.P.</given-names></name>
</person-group><article-title>Novel modifications of nonribosomal peptides from <italic toggle="yes">Brevibacillus laterosporus</italic> MG64 and investigation of their mode of action</article-title><source>Appl. Environ. Microbiol.</source><year>2020</year><volume>86</volume><fpage>e01981-20</fpage><pub-id pub-id-type="doi">10.1128/AEM.01981-20</pub-id><pub-id pub-id-type="pmid">32978140</pub-id></element-citation></ref><ref id="B55-microorganisms-10-01959"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rebets</surname><given-names>Y.</given-names></name>
<name><surname>Nadmid</surname><given-names>S.</given-names></name>
<name><surname>Paulus</surname><given-names>C.</given-names></name>
<name><surname>Dalem</surname><given-names>C.</given-names></name>
<name><surname>Hermann</surname><given-names>J.</given-names></name>
<name><surname>H&#x000fc;bner</surname><given-names>H.</given-names></name>
<name><surname>R&#x000fc;ckert</surname><given-names>C.</given-names></name>
<name><surname>Kiemer</surname><given-names>A.</given-names></name>
<name><surname>Gmeiner</surname><given-names>P.</given-names></name>
<name><surname>Kalinowski</surname><given-names>J.</given-names></name>
<etal/>
</person-group><article-title>Perquinolines A-C: Unprecedented bacterial tetrahydroisoquinolines involving an intriguing biosynthesis</article-title><source>Angew. Chem. Int. Ed.</source><year>2019</year><volume>58</volume><fpage>12930</fpage><lpage>12934</lpage><pub-id pub-id-type="doi">10.1002/anie.201905538</pub-id><?supplied-pmid 31310031?><pub-id pub-id-type="pmid">31310031</pub-id></element-citation></ref><ref id="B56-microorganisms-10-01959"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>Y.</given-names></name>
<name><surname>Bai</surname><given-names>J.</given-names></name>
<name><surname>Zhang</surname><given-names>L.</given-names></name>
<name><surname>Zhang</surname><given-names>C.</given-names></name>
<name><surname>Liu</surname><given-names>B.</given-names></name>
<name><surname>Hu</surname><given-names>Y.</given-names></name>
</person-group><article-title>Self-Resistance in the Biosynthesis of Fungal Macrolides Involving Cycles of Extracellular Oxidative Activation and Intracellular Reductive Inactivation</article-title><source>Angew. Chem. Int. Ed.</source><year>2021</year><volume>60</volume><fpage>6639</fpage><lpage>6645</lpage><pub-id pub-id-type="doi">10.1002/anie.202015442</pub-id><?supplied-pmid 33314510?><pub-id pub-id-type="pmid">33314510</pub-id></element-citation></ref><ref id="B57-microorganisms-10-01959"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Xiao</surname><given-names>F.</given-names></name>
<name><surname>Dong</surname><given-names>S.</given-names></name>
<name><surname>Liu</surname><given-names>Y.</given-names></name>
<name><surname>Feng</surname><given-names>Y.</given-names></name>
<name><surname>Li</surname><given-names>H.</given-names></name>
<name><surname>Yun</surname><given-names>C.-H.</given-names></name>
<name><surname>Cui</surname><given-names>Q.</given-names></name>
<name><surname>Li</surname><given-names>W.</given-names></name>
</person-group><article-title>Structural Basis of Specificity for Carboxyl-Terminated Acyl Donors in a Bacterial Acyltransferase</article-title><source>J. Am. Chem. Soc.</source><year>2020</year><volume>142</volume><fpage>16031</fpage><lpage>16038</lpage><pub-id pub-id-type="doi">10.1021/jacs.0c07331</pub-id><?supplied-pmid 32803979?><pub-id pub-id-type="pmid">32803979</pub-id></element-citation></ref><ref id="B58-microorganisms-10-01959"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ronan</surname><given-names>J.L.</given-names></name>
<name><surname>Kadi</surname><given-names>N.</given-names></name>
<name><surname>McMahon</surname><given-names>S.A.</given-names></name>
<name><surname>Naismith</surname><given-names>J.H.</given-names></name>
<name><surname>Alkhalaf</surname><given-names>L.M.</given-names></name>
<name><surname>Challis</surname><given-names>G.L.</given-names></name>
</person-group><article-title>Desferrioxamine biosynthesis: Diverse hydroxamate assembly by substrate-tolerant acyl transferase DesC</article-title><source>Philos. Trans. R. Soc. Lond. B Biol. Sci.</source><year>2018</year><volume>373</volume><pub-id pub-id-type="doi">10.1098/rstb.2017.0068</pub-id><?supplied-pmid 29685972?><pub-id pub-id-type="pmid">29685972</pub-id></element-citation></ref><ref id="B59-microorganisms-10-01959"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Alleyn</surname><given-names>M.</given-names></name>
<name><surname>Breitzig</surname><given-names>M.</given-names></name>
<name><surname>Lockey</surname><given-names>R.</given-names></name>
<name><surname>Kolliputi</surname><given-names>N.</given-names></name>
</person-group><article-title>The dawn of succinylation: A posttranslational modification</article-title><source>Am. J. Physiol. Cell Physiol.</source><year>2018</year><volume>314</volume><fpage>C228</fpage><lpage>C232</lpage><pub-id pub-id-type="doi">10.1152/ajpcell.00148.2017</pub-id><?supplied-pmid 29167150?><pub-id pub-id-type="pmid">29167150</pub-id></element-citation></ref></ref-list></back><floats-group><fig position="float" id="microorganisms-10-01959-f001"><label>Figure 1</label><caption><p>Chemical structures of the new myxochelin derivative myxochelin B-succinate (<bold>1</bold>), and the rediscovered congeners myxochelin B (<bold>2</bold>) and A (<bold>3</bold>) isolated from the myxobacterial strain MSr12020 (in grey box).</p></caption><graphic xlink:href="microorganisms-10-01959-g001" position="float"/></fig><fig position="float" id="microorganisms-10-01959-f002"><label>Figure 2</label><caption><p>High-performance liquid chromatography&#x02013;mass spectrometry base peak chromatogram (HPLC&#x02013;MS BPC) (grey) and extracted ion chromatograms (EICs) of <bold>1</bold> orange ([M+H]<sup>+</sup> 504.1976 <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic>, (orange), <bold>2</bold> ([M+H]<sup>+</sup> 404.1819 <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic>, blue), and <bold>3</bold> ([M+H]<sup>+</sup> 405.1658 <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic>, black) from myxobacterial MSr12020 crude extract.</p></caption><graphic xlink:href="microorganisms-10-01959-g002" position="float"/></fig><fig position="float" id="microorganisms-10-01959-f003"><label>Figure 3</label><caption><p>Carbon numbering, key <sup>1</sup>H-<sup>1</sup>H COSY and <sup>1</sup>H-<sup>13</sup>C HMBC correlations for <bold>1</bold>.</p></caption><graphic xlink:href="microorganisms-10-01959-g003" position="float"/></fig><fig position="float" id="microorganisms-10-01959-f004"><label>Figure 4</label><caption><p>Zone of inhibition assays on agar plate containing a soft agar overlay of the test microorganism <italic toggle="yes">Micrococcus luteus</italic> DSM 1790. (<bold>A</bold>) White paper disks contain the well-known antibacterial drug fusidic acid as positive control. (<bold>B</bold>) The white paper disk contains <bold>1</bold>. (<bold>C</bold>) The white paper disks contain <bold>2</bold>. (<bold>D</bold>) White paper disks contain MeOH as negative control.</p></caption><graphic xlink:href="microorganisms-10-01959-g004" position="float"/></fig><fig position="float" id="microorganisms-10-01959-f005"><label>Figure 5</label><caption><p>Proposed biosynthetic pathway leading to the formation of <bold>1</bold> alongside the previously identified congeners <bold>2</bold> and <bold>3</bold>, via the biosynthetic aldehyde intermediate <bold>4</bold>. Scheme adapted from Li et al. [<xref rid="B19-microorganisms-10-01959" ref-type="bibr">19</xref>]. Sphere: Biosynthetic domain, PCP: Peptidyl carrier protein; A: Adenylation domain, IC: isochorismate synthase, ArCP: Aryl carrier protein, C: Condensation domain, Red: Reduction domain.</p></caption><graphic xlink:href="microorganisms-10-01959-g005" position="float"/></fig><fig position="float" id="microorganisms-10-01959-f006"><label>Figure 6</label><caption><p>(<bold>A</bold>) HPLC&#x02013;MS BPCs of in vitro reactions with <bold>2.</bold> Only in the presence of succinyl-CoA (100-fold molar excess), the conversion of <bold>2</bold> to <bold>1</bold> was observed. (<bold>B</bold>) Production of <bold>1</bold> in reaction solution (1 &#x000b5;M <bold>2</bold> and 100 &#x000b5;M succinyl CoA) with different pH values observed as an HPLC&#x02013;MS EIC at 504.1983 &#x000b1; 0.05 Da [M+H]<sup>+</sup>. (<bold>C</bold>) Proposed mechanism for the non-enzymatic succinylation of <bold>2</bold> during the biosynthesis of <bold>1</bold>. The proposed reactive cyclic succinic anhydride intermediate might react in a dose-dependent manner [<xref rid="B49-microorganisms-10-01959" ref-type="bibr">49</xref>].</p></caption><graphic xlink:href="microorganisms-10-01959-g006" position="float"/></fig><fig position="float" id="microorganisms-10-01959-f007"><label>Figure 7</label><caption><p>Selected examples of microbial natural products featuring a succinyl substructure. While the succinylation of berkeleylactone E, A26771B, 7-O-succinyl macrolactin A and HSC are catalyzed by acyl-transferase-like proteins (succinyl moiety colored in blue), the succinylation of <bold>1</bold> and suc-K11/suc-K20-BacSp222 occurs non-enzymatically (succinyl moiety colored in orange). The succinylation of the succilins and cerexins remains elusive (succinyl moiety colored in grey).</p></caption><graphic xlink:href="microorganisms-10-01959-g007" position="float"/></fig><table-wrap position="float" id="microorganisms-10-01959-t001"><object-id pub-id-type="pii">microorganisms-10-01959-t001_Table 1</object-id><label>Table 1</label><caption><p>Antimicrobial activity of myxochelin-B-succinate (<bold>1</bold>), myxochelin B (<bold>2</bold>), myxochelin A (<bold>3</bold>) and different well-known antimicrobial drugs as control against common microbial pathogens. NT: not tested.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</th><th colspan="7" align="center" valign="middle" style="border-top:solid thin" rowspan="1">Zone of Inhibition in mm</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Microorganism</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Kanamycin</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fusidic Acid</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cycloheximide</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MeOH/DMSO</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">Escherichia coli</italic> HS 996</td><td align="center" valign="middle" rowspan="1" colspan="1">6</td><td align="center" valign="middle" rowspan="1" colspan="1">6</td><td align="center" valign="middle" rowspan="1" colspan="1">6</td><td align="center" valign="middle" rowspan="1" colspan="1">30</td><td align="center" valign="middle" rowspan="1" colspan="1">NT</td><td align="center" valign="middle" rowspan="1" colspan="1">NT</td><td align="center" valign="middle" rowspan="1" colspan="1">6</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">E. coli</italic> BW251123</td><td align="center" valign="middle" rowspan="1" colspan="1">6</td><td align="center" valign="middle" rowspan="1" colspan="1">6</td><td align="center" valign="middle" rowspan="1" colspan="1">6</td><td align="center" valign="middle" rowspan="1" colspan="1">32</td><td align="center" valign="middle" rowspan="1" colspan="1">NT</td><td align="center" valign="middle" rowspan="1" colspan="1">NT</td><td align="center" valign="middle" rowspan="1" colspan="1">6</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">Micrococcus luteus</italic> DSM 1790</td><td align="center" valign="middle" rowspan="1" colspan="1">40</td><td align="center" valign="middle" rowspan="1" colspan="1">40</td><td align="center" valign="middle" rowspan="1" colspan="1">6</td><td align="center" valign="middle" rowspan="1" colspan="1">NT</td><td align="center" valign="middle" rowspan="1" colspan="1">44</td><td align="center" valign="middle" rowspan="1" colspan="1">NT</td><td align="center" valign="middle" rowspan="1" colspan="1">6</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">Bacillus subtilis</italic> DSM 10</td><td align="center" valign="middle" rowspan="1" colspan="1">6</td><td align="center" valign="middle" rowspan="1" colspan="1">10</td><td align="center" valign="middle" rowspan="1" colspan="1">6</td><td align="center" valign="middle" rowspan="1" colspan="1">NT</td><td align="center" valign="middle" rowspan="1" colspan="1">27</td><td align="center" valign="middle" rowspan="1" colspan="1">NT</td><td align="center" valign="middle" rowspan="1" colspan="1">6</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">Mucor hiemalis</italic> DSM 2656</td><td align="center" valign="middle" rowspan="1" colspan="1">6</td><td align="center" valign="middle" rowspan="1" colspan="1">6</td><td align="center" valign="middle" rowspan="1" colspan="1">6</td><td align="center" valign="middle" rowspan="1" colspan="1">NT</td><td align="center" valign="middle" rowspan="1" colspan="1">NT</td><td align="center" valign="middle" rowspan="1" colspan="1">15</td><td align="center" valign="middle" rowspan="1" colspan="1">6</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Pichia anomala</italic> DSM 6766</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NT</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NT</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">52</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6</td></tr></tbody></table></table-wrap><table-wrap position="float" id="microorganisms-10-01959-t002"><object-id pub-id-type="pii">microorganisms-10-01959-t002_Table 2</object-id><label>Table 2</label><caption><p>Cytotoxic activity of myxochelin-B-succinate (<bold>1</bold>), myxochelin B (<bold>2</bold>), myxochelin A (<bold>3</bold>) and doxorubicin (well-known cytotoxic drug) as control.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</th><th colspan="4" align="center" valign="middle" style="border-top:solid thin" rowspan="1">IC<sub>50</sub> Values of 1&#x02013;3 in &#x003bc;g/mL</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cancer Cell Line</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Doxorubicin</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">HCT-116</td><td align="center" valign="middle" rowspan="1" colspan="1">23.3</td><td align="center" valign="middle" rowspan="1" colspan="1">23.2</td><td align="center" valign="middle" rowspan="1" colspan="1">24.3</td><td align="center" valign="middle" rowspan="1" colspan="1">0.1</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">KB-3-1</td><td align="center" valign="middle" rowspan="1" colspan="1">22.7</td><td align="center" valign="middle" rowspan="1" colspan="1">21.2</td><td align="center" valign="middle" rowspan="1" colspan="1">41.7</td><td align="center" valign="middle" rowspan="1" colspan="1">0.6</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">U-2 OS</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">31.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">29.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">34.6</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.2</td></tr></tbody></table></table-wrap></floats-group></article>